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Kurzzusammenfassung 
Kurzzusammenfassung 
Schilddrüsenhormone spielen eine wesentliche Rolle für die Entwicklung und Homöostase von fast allen 
Geweben. Dies wird besonders deutlich im Falle des kongenitalen Hypothyroidismus, der in ungefähr 1 von 
3600 Geburten auftritt und häufig durch Schilddrüsendys- oder –agenese verursacht wird. Wenn er nicht sofort 
mit Thyroxin (T4) behandelt wird, führt der kongenitale Hypothyroidismus zu Stoffwechselstörungen, 
verzögertem Wachstum, neurologischen Schäden und geistiger Retardierung. Die Pax8-/- Maus ist ein ideales 
Modellsystem für den kongenitalen Hypothyroidismus, da ihr von Geburt an die follikulären Strukturen der 
Schilddrüse fehlen und sie athyroid aufwächst. Als Folge zeigen diese Mäuse Ataxie, Taubheit, 
Wachstumsverzögerung sowie eine komplett gestörte Zusammensetzung der Adenohypophyse und sie überleben 
die Entwöhnungsphase nicht. Ziel dieser Doktorarbeit war die Untersuchung der molekularen Mechanismen 
einiger dieser Defekte. 
Es wurden Pax8-/-TRα1-/- Doppelmutanten erzeugt, um die von einer anderen Arbeitsgruppe aufgestellte 
Hypothese zu überprüfen, dass der Schilddrüsenhormonrezeptor (TR) α1 in ungebundenem Zustand als 
Aporezeptor für die Mortalität in athyroiden Mäusen verantwortlich ist (Flamant et al. 2002). Die Pax8-/-TRα1-/- 
Doppelmutanten wiesen jedoch den gleichen Phänotyp wie Pax8-/- Mäuse auf, inklusive verzögertem Wachstum, 
gestörter Zusammensetzung der Adenohypophyse und Letalität, woraus geschlussfolgert werden kann, dass die 
Sterblichkeit kein Resultat der Aporezeptoraktivität des TRα1 ist. Sie wird vermutlich durch die zweite 
Schilddrüsenhormonrezeptorisoform des TRα Gens, TRα2, verursacht, die in den Doppelmutanten noch 
exprimiert wird. 
Um die gestörte Zusammensetzung der Hypophyse in Pax8-/- Mäusen zu analysieren, wurde eine Mikroarray-
Analyse durchgeführt, bei der Gene identifiziert werden konnten, die in dieser Maus im Vergleich zum Wildtyp 
unterschiedlich exprimiert sind. Unter anderem ist die Expression der Tyrosinhydroxylase in diesen Mäusen 
stark erhöht, was zu einer verstärkten lokalen Synthese von Dopamin führt, das die Expression von Prolaktin 
mRNA unterdrückt. Dopamin behindert allerdings nicht die Entwicklung der laktotrophen Zellen, wie durch 
Experimente mit Dopaminagonisten und –antagonisten gezeigt werden konnte. Weiterhin wurde mit Annexin A5 
ein Gen identifiziert, das positiv durch Schilddrüsenhormone reguliert wird und wie die Analyse Annexin A5 
defizienter Mäuse ergab, vermutlich die Synthese der Gonadotropine stimuliert. 
Während normalerweise alle Symptome des kongenitalen Hypothyroidismus durch Therapie mit T4 reversibel 
sind, bleiben T4 behandelte Pax8-/- Mäuse beiderlei Geschlechts überraschend unfruchtbar. Die Analyse zeigte, 
dass T4-behandelte Pax8 defiziente Weibchen keinen Uterus und keine Vaginalöffnung besitzen, während die 
Männchen in der Epididymis keine Spermien aufweisen. Da sowohl die mRNA Expression der hypophysären 
Hormone als auch die Serumspiegel der Steroidhormone in Pax8-/- Mäusen durch T4-Behandlung normalisiert 
werden, scheinen diese Defekte eine direkte Folge der Pax8 Inaktivierung zu sein, zumal Pax8 mRNA in den 
Epithelien von Uterus und Eileiter, sowie Ductus efferentis und Epididymis nachgewiesen werden konnte. Da 
ebenfalls eine Pax8 Expression im Epithel menschlicher Endometrien gefunden wurde, ist dringend anzuraten, 
zu überprüfen, ob Patienten mit einer Pax8 Mutation in ähnlicher Weise betroffen sind. 
 
Schlagworte: Kongenitaler Hypothyroidismus, Hypophyse, Infertilität 
Abstract 
 
Abstract 
Thyroid hormones are essential for normal vertebrate development and for the metabolic homeostasis of almost 
all tissues. The physiological importance of thyroid hormone becomes most evident under the conditions of 
congenital hypothyroidism, a common disorder occurring in 1 among 3600 newborns. If not treated immediately 
after birth by thyroxine (T4) substitution, congenital hypothyroidism leads to the syndrome of cretinism that is 
characterized by metabolic disturbances, severe neurological defects, mental deficiencies and growth retardation. 
The Pax8-/- mouse is an ideal animal model to study the consequences of congenital hypothyroidism, since these 
mice are born without thyroid follicular structures and therefore they are completely athyroid in postnatal life. 
Consequently, Pax8 null mice exhibit ataxia, deafness, growth retardation, a completely distorted cellular 
composition of the anterior pituitary and they do not survive weaning. The analysis of the underlying molecular 
mechanisms of some of these symptoms was part of this thesis.  
Pax8-/-TRα1-/- double mutants were generated, since it has been speculated that the unliganded thyroid hormone 
receptor (TR) α1 acting as an aporeceptor might be responsible for the mortality of Pax8-/- mice. These 
compound mutants exhibited the same phenotype as Pax8-/- mice, including growth retardation, a deranged 
appearance of the pituitary and death around weaning. Therefore we can conclude that the mortality is not 
caused by TRα1 aporeceptor activity but rather by the other isoform of the TRα gene, TRα2. 
A microarray based analysis was used to identify factors which contribute to the distorted cellular make-up of 
the pituitary in athyroid mice. Several genes were found to be differentially expressed in these animals, among 
them tyrosine hydroxylase which was upregulated in Pax8-/- mice, leading to an increased local production of 
dopamine. This dopamine inhibits prolactin mRNA expression, but not postnatal lactotroph development as 
demonstrated by the use of dopamine antagonists and agonists. Additionally, annexin A5 was identified as a 
pituitary gene which is positively regulated by thyroid hormones and seems to stimulate gonadotropin synthesis 
as revealed by the analysis of annexin A5 deficient mice. 
Although usually all symptoms of congenital hypothyroidism can be reversed by thyroid hormone replacement 
therapy, T4-treated Pax8-/- mice of both genders were infertile. The analysis revealed that Pax8 deficient females 
entirely lack the uterus and do not have a vaginal opening, whereas male mice do not have any sperm in the 
epididymis and exhibit testicular atrophy due to a narrowed passage in the efferent ducts. Since neither the 
mRNA expression of adenohypophyseal hormones nor the serum levels of steroid hormones were impaired in 
T4-treated mice, this defect seems to be directly related to the inactivation of the Pax8 gene, which was 
supported by the identification of Pax8 mRNA expression in the epithelium of the uterus and the oviducts as 
well as the epithelium of the efferent ducts and the epididymis of wildtype mice. Since Pax8 mRNA expression 
was also demonstrated in human endometrial tissue samples, it remains to be elucidated whether human patients 
with mutations in the Pax8 gene are similarly affected. 
 
Keywords: Congenital Hypothyroidism, Pituitary, Infertility 
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1. Introduction 
1.1. The Endocrine System 
The endocrine system represents a very important communication pathway comparable in 
complexity to the central nervous or the immune system. It controls essential processes like 
reproduction, growth, energy consumption, and temperature homeostasis by messenger 
substances called hormones which are produced by specialized glands and subsequently 
released into the systemic circulation. These hormones then act on distant target cells by 
binding to specific hormone receptors. 
The anterior pituitary is the master gland of the endocrine system. It influences several target 
tissues such as the thyroid gland by the secretion of thyroid stimulating hormone (TSH), the 
mammary gland by the release of prolactin (PRL), liver and bone through growth hormone 
(GH), the reproductive system by follicle stimulating hormone (FSH) and luteinizing 
hormone (LH), and the adrenal cortex by adrenocorticotrophic hormone (ACTH). The activity 
of the anterior pituitary itself is controlled by the hypothalamus which integrates information 
from higher brain regions. The first hypothalamic hypophysiotropic neuropeptide hormone 
identified was thyrotropin releasing hormone (TRH), a tripeptideamide with the sequence 
pyro-Glu-His-Pro-NH2 (Guillemin 1978; Schally 1978). As the name implies, TRH stimulates 
the secretion of TSH from the anterior pituitary. Subsequent studies in man (Jacobs et al. 
1971) and with cultured rat pituitary tumor cells (Tashjian et al. 1971) then demonstrated that 
TRH is also effective as a PRL secretagogue. Besides the stimulating effect of TRH, PRL 
secretion is mainly controlled by tonic inhibition through hypothalamic dopamine (Ben-
Jonathan et al. 2001). 
In addition to the hypothalamic control, the synthesis and the secretion of most anterior 
pituitary hormones is also regulated by negative feedback loops, for example TSH, which 
stimulates synthesis and release of thyroid hormone (TH) from the thyroid gland. TH in turn 
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inhibits the synthesis of TRH and TSH on the level of the hypothalamus or the pituitary 
respectively (Fig. 1.1). 
 
Fig. 1.1: The production of TH is modulated by TRH from the hypothalamus and TSH from the pituitary; both 
hormones in turn are negatively regulated by TH. 
 
1.2. Thyroid Hormones 
THs are essential for proper vertebrate development and the homeostasis of almost all tissues 
(Porterfield and Hendrich 1993, Oppenheimer and Schwartz 1997, Jones et al. 2005, Bernal 
2005). They are involved in the regulation of body temperature and oxygen consumption, the 
metabolism of lipids and carbohydrates, and they also affect growth, differentiation and 
development (Yen 2001, Bernal 2005). The secretory products of the thyroid gland are mainly 
T4 (thyroxine, tetraiodothyronine) and to a lower extent T3 (triiodothyronine). Since T3 is the 
receptor active form, a conversion of the prohormone T4 is required before any receptor-
mediated action on target tissues. The conversion of T4 to T3 is carried out by three enzymes 
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called deiodinases (D1, D2, and D3) that catalyze either outer (D1 and D2) or inner ring 
deiodination (D1 and D3) which activates or inactivates TH (Fig. 1.2). 
 
Fig. 1.2: Activation and inactivation of thyroid hormones by the different deiodinases (Bianco et al. 2002) 
 
The majority of TH effects are mediated through the binding of T3 to nuclear hormone 
receptors that regulate the expression of T3-sensitive genes (Yen et al. 2003). These TH 
receptors (TRs) are encoded by two different genes, TRα and TRβ, that give rise to eight 
different splice variants (TRα1, -α2, -∆α1, -∆α2, -β1, -β2, -β3, and –∆β3).  
 
Fig. 1.3: The two different TR genes which give rise to 8 different splice variants. Only four of them are capable 
of binding DNA (black box labeled DNA) and T3 (blue box labeled T3) (O’Shea and Williams 2002). 
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However, only four of these isoforms (TRα1, -β1, -β2, and –β3) are considered to act as 
functional TRs, because they contain a ligand- as well as a DNA-binding domain (O’Shea and 
Williams 2002). The nonbinding isoforms have been discussed to act as dominant negative 
antagonists as deduced from in vitro experiments; however, their physiological role in vivo is 
still poorly defined (Chassande et al. 1997). 
Corresponding to the vast array of TH effects on body homeostasis, TRs are found in almost 
every tissue, with TRα1 more ubiquitously expressed than TRβ isoforms. Mutant mice 
deficient in the expression of one or both TRs have been generated to assign certain TH 
effects to specific TR isoforms. Analysis of TRβ deficient mice revealed that this TR plays an 
important role in cochlear and retina development as well as TSH feedback regulation 
(Forrest et al. 1996), whereas the phenotype of TRα1 null mouse suggests a predominant role 
of TRα1 in the regulation of heart rate and body temperature (Wikström et al. 1998). Even 
mice devoid of all TRs (TRα1-/-TRβ-/- mice) are surprisingly viable although severely growth 
retarded and poorly fertile (Göthe et al. 1999). In contrast to the absence of all functional TRs, 
congenital hypothyroid Pax8 null mice which lack TH as ligand do not survive weaning 
indicating that unliganded TRs exert lethal aporeceptor-effects in these mice (Mansouri et al. 
1998, Flamant et al. 2002). 
 
1.3. Congenital Hypothyroidism 
The importance of TH becomes most evident under the conditions of congenital 
hypothyroidism (CH), a disorder occurring in 1 among 3600 newborns which is mainly 
caused by thyroid dys- or agenesis (Kopp et al. 2002, De Felice and DiLauro 2004). If not 
treated immediately after birth with TH, severe forms of CH lead to cretinism, a syndrome 
characterized by growth retardation, metabolic disturbances and severe neurological deficits 
(Roberts and Ladenson 2004, Bernal 2005). 
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Among other genes, CH in humans has been associated with mutations in the paired-box gene 
8 (Pax8), which result in severe thyroid hypoplasia (Macchia et al. 1998). Correspondingly, in 
mice where the Pax8 gene has been deleted, the thyroid gland is completely devoid of TH-
producing follicular cells (Mansouri et al. 1998). Thus, these athyroid mice provide an ideal 
animal model to study the consequences of CH, especially since no further defects have been 
observed in other tissues expressing Pax8 such as the kidney or some hindbrain regions, 
which is probably explained by a partial redundancy of the highly homologous Pax2 and Pax5 
gene products (Mansouri et al. 1994, Mansouri et al. 1998). 
Due to their athyroidism, Pax8 deficient animals exhibit a severe phenotype. They are growth 
retarded, ataxic, deaf, and do not survive weaning (Mansouri et al. 1998). The lack of TH also 
affects the appearance of the pituitary gland which shows hypertrophy and hyperplasia of the 
thyrotrophs, a reduced number of somatotrophs and an almost complete absence of 
lactotrophs (Friedrichsen et al. 2004). As in humans, all these disturbances can be reversed by 
the timely institution of TH replacement therapy directly after birth (Larsen et al. 2003, 
Friedrichsen et al. 2004, Christ et al. 2004, Roberts and Ladenson 2004). 
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1.4. Aim of this Project 
Thyroid hormones play an essential role in various aspects of development, homeostasis and 
metabolism. The Pax8 null mouse is a valuable animal model to identify the effects of TH 
action, because it is born without a functional thyroid gland and thus athyroid in postnatal life. 
The aim of this thesis is to reveal molecular mechanisms underlying TH action using Pax8-/- 
mice and mouse mutants with deficiencies in TH receptor (TR) genes. The analysis of 
congenital hypothyroid Pax8 deficient mice should be focussed on three aspects namely the 
pre-weaning mortality, the completely distorted appearance of the anterior pituitary, and the 
infertility of TH-substituted Pax8-/- mice. 
To investigate the mortality of Pax8 null mice in more detail, the analysis included Pax8-/-
TRα1-/- mice which lack TH and TRα1, the only isoform from the TRα gene that is capable of 
binding T3 and DNA. Since it has been reported before that Pax8-/- mice can be rescued by 
the complete inactivation of the TRα-gene (Pax8-/-TRα0/0 double mutant mice; Flamant et al. 
2002), it might be possible to assign the mortality to one specific TRα isoform, depending on 
the survival of the Pax8-/-TRα1-/- double mutant mice. 
The identification of TH dependent factors contributing to the deranged composition of the 
anterior pituitary should be pursued by comparing the gene expression in pituitaries of 
wildtype and Pax8 deficient mice using microarray technologies. Genes found to be 
differentially expressed should be validated by in situ hybridization or quantitative Real-Time 
PCR and analyzed especially with regard to a possible involvement in the regulation of 
prolactin mRNA expression and lactotroph development. 
Although most defects observed in congenital hypothyroidism are usually normalized by TH 
treatment, Pax8 null mice of both genders are infertile despite proper thyroxine substitution. It 
is also part of this study to investigate the cause for this infertility by careful histological and 
endocrine analysis in order to determine whether this defect is related to disturbances in TH 
metabolism or directly caused by the inactivation of the Pax8 gene. 
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2. Materials and Methods 
2.1. Experimental Animals and Human Tissue Samples 
Animal procedures were approved by the animal welfare committee of the Medizinische 
Hochschule Hannover. Mice were kept at constant temperature (22°C) and light cycle (12-h 
light, 12-h dark) and were provided with standard laboratory chow and tap water ad libitum. If 
indicated, animals were injected with thyroxine (18 ng/g BW sc), bromocryptine (10 µg/g 
BW ip) or haloperidol (1 µg/g BW ip or sc). Haloperidol (Sigma, Schnelldorf, Germany) was 
dissolved in 0.9% NaCl containing 0.1 M hydrochloric acid at a final concentration of 1 
mg/ml. Bromocryptine was dissolved in 8 mg/ml tartaric acid at a final concentration of 8 
mg/ml. 
If not stated otherwise, animals were killed by decapitation at postnatal day 21 (P21); tissues 
isolated quickly, frozen on dry ice, and stored at –80°C until further processing. Serum was 
obtained from trunk blood by centrifugation and stored at –80°C.  
Pax8+/- mice (Mansouri et al. 1998) were obtained from Ahmed Mansouri and Peter Gruss 
(Göttingen, Germany). TRα1-/- (Wikstöm et al. 1998) and TRβ-/- mice (Forrest et al. 1996) 
were obtained from the Jackson Laboratory (Bar Harbor, ME, USA), TRα1-/-TRβ-/- double 
mutant mice were generated by intercrossing these mice. TRH-R1-/- mice were generated as 
described previously (Rabeler et al. 2004). Annexin A5-/- mice (Brachvogel et al. 2003) were 
obtained from Bent Brachvogel and Ernst Poeschl (University of Erlangen, Germany). TRα2-/- 
mice (Salto et al. 2001) were obtained from Björn Vennström (Karolinska Institute, 
Stockholm, Sweden). Wildtype controls were either littermates (Pax8, A5) or age- and strain-
matched controls of the mice analyzed. Genotyping was performed using standard PCR 
assays with the primers indicated below. 
Endometrial tissue was obtained from women undergoing endometrial biopsy or 
hysterectomy at the department of Gynecology, University Hospital Essen, Germany. 
Institutional ethical approval was obtained and all women provided written informed consent. 
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The stage of the menstrual cycle was confirmed by serum hormone determination using 
competitive immunoassays for estrogen (Bayer Diagnostics 06792063) as well as 
progesterone (Bayer Diagnostics 01586287, Leverkusen, Germany) and by histological 
staging (Noyes et al. 1975). Progesterone concentrations above 1.0 ng/ml were allocated to 
the secretory phase, samples below that level were allocated to the proliferative phase. 
Gene Primer (5’ – 3’) 
TRα1 GGAGTCGACCGAGAAGAGTCAGGA 
GTATGGGAGCTGCATCTATCCAAG 
CACTGCATTCTAGTTGTGGT 
TRα2 CACTGCATTCTAGTTGTGGT 
GGACAAGATCGAGAAGAGTCAGGA 
GAAGGGAAATCTAGGCCAAGGAAC 
TRβ CCCTGGAGGCCAAAGGTCATCAATG 
GTGCCAGCGGGGCTGCTAAAG 
GCACAGGGAGGAAGTAGGCTGTTCT 
Pax8 GGATGTGGAATGTGTGCGAGG 
GATGCTGCCAGTCTCGTAG 
GCTAAGAGAAGGTGGATGAGAG 
TRH-R1 GTGCTGTTGAAGCATCTG 
GACTGTCCTGGCCGTAAC 
TGAGTGTGGCTTGATTGG 
Anxa5 CCTGTACTCTATCACTATCACTGACTGTTAATC 
CGAGAGGCACTGTGACTGACTTCCCTGGAT 
GCCAGTTTGAGGGGACGACGACAG 
GAAGCAATGCTCAGCGCCAGGA 
Table 2.1: Primers used for PCR genotyping of the genes indicated 
 
2.2. RNA Isolation, cDNA Synthesis and Microarray Analysis 
Total RNA was isolated from pools of 3-5 mouse pituitaries using the Absolutely Microprep 
RNA Isolation Kit (Stratagene, LaJolla, USA). cDNA synthesis was performed using the 
Thermoscript RT System (Invitrogen, CA, USA) according to the instructions of the 
manufacturer. A sample without reverse transcriptase was used as negative control to confirm 
the absence of genomic DNA. The microarray analysis was done using the U430A gene chip 
(Affymetrix, High Wycombe, UK) that contains more than 34.000 mouse genes. The 
hybridization and the read-out of the raw data were carried out by Dr. Ludger Klein-Hitpaß at 
the Microarray Facility of the University Essen (Germany). 
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2.3. In Situ Hybridization 
Tissues were rapidly removed from the decapitated animals and embedded in Tissue-Tek 
medium (Sakura Finetek, Torrance, USA) and frozen on dry ice. Sections (16 µm) were cut 
on a cryostat (Leica, Bentheim, Germany), thaw-mounted on silane-treated slides, and stored 
at –80°C until further processing. In situ hybridization histochemistry (ISH) was carried out 
according to Schäfer et al. (Schäfer et al. 1995). Frozen sections were fixed in a 4% 
phosphate-buffered paraformaldehyde (PFA) solution (pH 7.4) for 1 h at room temperature 
(RT), rinsed with phosphate buffered saline (PBS) and treated with 0.4% phosphate buffered 
Triton X100 solution for 10 min. After washing with PBS and water, tissue sections were 
incubated in 0.1 M triethanolamine (pH 8) containing 0.25% (v/v) acetic anhydride for 10 
min. Following acetylation, sections were rinsed several times with PBS, dehydrated by 
successive washing with increasing ethanol concentrations, and air dried. 
Radioactive-labeled probes were generated from cDNA subclones in pGEM Teasy plasmids 
as listed below. In vitro transcription was carried out according to standard protocols with 
(35S)-UTP and (35S)-CTP as labeled nucleotides (Melton et al. 1984).  
Radioactive cRNA probes were diluted in hybridization buffer (50% formamide, 10% 
dextrane sulfate, 0.6 M NaCl, 10 mM Tris·HCl pH 7.4, 1x Denhardt's solution, 100 µg/ml 
sonicated salmon sperm DNA, 1 mM EDTA and 10 mM dithiothreitol) to a final 
concentration of 5x104 cpm/ml. After application of the hybridization mix, sections were 
coverslipped and incubated in a humid chamber at 58°C for 16 h. Following hybridization, 
coverslips were removed in 2x standard saline citrate (SSC: 0.3 M NaCl, 0.03 M sodium 
citrate, pH 7.0). The sections were then treated with RNAse A (20 µg/ml) and RNAse T1 (1 
U/ml) at 37°C for 30 min. Successive washes followed at room temperature (RT) in 1x, 0.5x 
and 0.2x SSC for 20 min each and in 0.2x SSC at 65°C for 1 h. The tissue was dehydrated and 
exposed to Biomax MR Film (Kodak, Sigma Aldrich, Germany) for 48 h. For microscopic 
analysis, sections were dipped in NTB2 emulsion (Kodak, Integra Biosciences, Germany) and 
Materials and Methods 
 10
stored at 4°C. After exposure for 14 days, autoradiograms were developed in D19 (Kodak, 
Sigma-Aldrich, Germany) for 4 min and fixed in Rapid Fix (Kodak, Sigma-Aldrich, 
Germany) for 4 min. If required, sections were counterstained with cresyl violet and then 
photographed under darkfield or brightfield illuminations. 
Digoxigenin-labeled probes were generated from cDNA subclones in pGEM Teasy plasmids 
(Promega, Mannheim, Germany) as listed below using a DIG RNA Labeling Kit (Boehringer, 
Mannheim, Germany). In vitro transcription was carried out according to standard protocols.  
The digoxigenin labeled probes were diluted in hybridization buffer to a final concentration of 
5 ng/µl. Hybridization and posthybridization were performed as described above for 
radioactive in situ hybridization. Sections were then rinsed with P1 (100 mM Tris, 150 mM 
NaCl, pH 7.5) and incubated for 2 h in blocking solution provided by the manufacturer of the 
kit. After incubation overnight with anti-digoxigenin antibody conjugated with alkaline 
phosphatase (1:1000 dilution; Boehringer, Mannheim, Germany), the tissue sections were 
washed with P1. Staining proceeded for 2 to 6 h in substrate solution containing NBT 
(nitroblue tetrazolium chloride, 340 µg/ml; Biomol, Hamburg, Germany), X-Phosphate (5-
bromo-4-chloro-3-indolyl phosphate, 175 µg/ml; Biomol, Hamburg, Germany), 100 mM Tris, 
100 mM NaCl and 50 mM MgCl2, pH 9.0. 
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cDNA vector size fragment NCBI 
accession no 
linearized 
with 
RNA polymerase 
and orientation 
GH pLS 198bp nt 248-445 U62779 HindIII 
PstI 
T7 (antisense) 
T3 (sense) 
β-TSH pLS 254bp nt 190-445 M109902 HindIII 
PstI 
T7 (antisense) 
T3 (sense) 
β-FSH pLS 880bp nt 1-879 M36804 HindIII 
PstI 
T7 (sense) 
T3 (antisense) 
prolactin pLS 184bp nt 1566-1749 J00769 HindIII 
PstI 
T7 (antisense) 
T3 (sense) 
POMC pGEM4 471bp nt 56-526 J00759 XbaI 
HindIII 
T7 (antisense) 
Sp6 (sense) 
β-LH pLS 457bp nt 1-457 NM_012858 XbaI 
BamHI 
T3 (antisense) 
T7 (sense) 
deiodinase  
type II 
pGEM 
Teasy 
914bp nt 131-1045 AF096875 SacII 
SacI 
SP6 (antisense) 
T7 (sense) 
tyrosine 
hydroxylase 
pGEM 
Teasy 
1109bp nt 616-1724 NM_009377 SpeI 
SacII 
T7 (sense) 
SP6 (antisense) 
dopamine 
receptor 2 
pGEM 
Teasy 
2110bp nt 31-2140 XM_125162 SpeI 
AatII 
T7 (sense) 
SP6 (antisense) 
pax8 (*) pGEM 
Teasy 
190bp nt 887-1177 NM_011040 SacII 
SpeI 
SP6 (antisense) 
T7 (sense) 
AnxA1 (*) pGEM 
Teasy 
330bp nt 632-962 NM_010730 SpeI 
SacII 
SP6 (antisense) 
T7 (sense) 
AnxA5 (*) pGEM 
Teasy 
429bp nt 529-958 D63423 SpeI 
SacII 
T7 (antisense) 
SP6 (sense) 
AnxA10 (*) pGEM 
Teasy 
448bp nt 575-1023 NM_011922 SpeI 
SacII 
T7 (antisense) 
SP6 (sense) 
calbindin 2 (*) pGEM 
Teasy 
388bp nt 692-1080 NM_007586 SpeI 
SacII 
T7 (antisense) 
SP6 (sense) 
calsequestrin 2 
                      (*) 
pGEM 
Teasy 
564bp nt 1069-1633 MMU91483 SpeI 
SacII 
T7 (antisense) 
SP6 (sense) 
STAT1 (*) pGEM 
Teasy 
314bp nt 167-481 NM_009283 SpeI 
SacII 
T7 (sense) 
SP6 (antisense) 
STAT4 (*) pGEM 
Teasy 
393bp nt 2030-2423 NM_011487 SpeI 
SacII 
T7 (antisense) 
SP6 (sense) 
 
Table 2.2: List of all plasmids with cDNA inserts that were used for probe generation. The plasmids have been 
generated either during this study (*) or they were generously provided by Dr. Heike Heuer, Dr. Martin Schäfer 
and Dr. Sönke Friedrichsen. 
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2.4. Quantitative Real-Time PCR 
Quantitative Real-Time PCR was performed using the iCycler iQ Multi-Color Real-Time 
PCR Detection System and the iQ SYBR Green Supermix (Biorad, Munich, Germany). 
Cyclophilin was used as housekeeping gene for normalization. The following primers were 
chosen to generate the PCR-fragments: 
Gene Primer (5’ – 3’) 
Cyclophilin GCAAGGATGGCAAGGATTGA 
AGCAATTCTGCCTGGATAGC 
β-TSH CCGCACCATGTTACTCCTTA 
GTTCTGACAGCCTCGTGTAT 
prolactin GCAGTCACCATGACCATGAA 
AGATTGGCAGAGGCTGAACA 
GH CGCTTCTCGCTGCTGCTCAT 
GTCCGAGGTGCCGAACATCA 
β-FSH CGCACACCAAGTGGTATTGA 
AGAGCAATCTGCTGCCATAG 
β-LH AGTACTCGGACCATGCTAGG 
CAACTCTGGCCGCAGAGAAT 
AnxA1 TTCCTCAAGCAGGCCCGTTT 
TAAGTACGCGGCCTTGATCT 
AnxA2 GTCTACTGTCCACGAAATCC 
TCTCCAGGTGGCCAGATAAG 
AnxA3 TCACCTTCGGCTGAGCTTCTG 
CCTGTTCATACGCTGCTTGG 
AnxA4 TCTCCGCACCAGAGGAACTT 
TTGCTGCTCAGCTCCGACTT 
AnxA5 TTGGCGTGTGCATCGGTCCT 
TGGCGCTGAGCATTGCTTCG 
AnxA6 TCTGCTGCAGAACCTGAGAC 
TCACTATCAGCCGCTCGAAC 
AnxA7 CTGCAGGTCAGGAGTCATCT 
TGTGCAGGTGGCTGTGGATA 
AnxA8 CACTGAGCAGAGGCCAACTA 
CCTCTTGGTGAGCACGTCTA 
AnxA9 GTGCTTCACGACGCTGAACC 
CCACACCTTGGCCTGCGATA 
AnxA10 TACCCTGGTTACTTCCTCTC 
GGCCATACATGCTCTGATAG 
AnxA11 GCTGGATAACGTAGCCAACT 
GGCGGATACATTCCATAAGG 
AnxA13 GTCTTATCCAGCAGGACATC 
TGTTGCTTCGTGTGCATAGG 
deiodinase 
type II 
GGAACAGCTTCCTCCTAGAT 
GGTCTTCTCCGAGGCATAAT 
tyrosine 
hydroxylase 
GCTGGAGGATGTGTCTCACT 
GAGGAGGCATGACGGATGTA 
dopa 
decarboxylase 
GACTACAGGCACTGGCAGAT 
CTGGCGTACCAGTGACTCAA 
TRα1 GAGGCTAGGACCCAAGTTCT 
CCTCCTGACCCTACAGTCAA 
TRβ  GTGACACGAGGCCAGCTGAA 
TAGCAGGACGGCCTGAAGCA 
Table 2.3: Primers used to generate cDNA fragments for quantitative Real-Time PCR 
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2.5. SDS-Polyacrylamide-Gelelectrophoresis and Western Blot 
Pools of 3-5 pituitaries of each genotype were homogenized in 50 µl of 100 mM HEPES pH 
7.0 and tissue remnants were separated by centrifugation. Subsequently, 10 µl of the 
supernatant containing the proteins were separated on a 7% SDS-Polyacrylamidegel 
according to standard protocols. Proteins were then transferred to a nitrocellulose membrane 
(Optitran BA-S 83; Schleicher and Schuell, Dassel, Germany) by a semi-dry Western Blot 
protocol. Membranes were then blocked with 3% BSA in PBS. Annexin A5 was detected 
with a polyclonal rabbit anti-annexin A5 antibody (1:3000; Hyphen, Biomed, Neuville, 
France), tyrosine hydroxylase with a mouse monoclonal anti-tyrosine hydroxylase antibody 
(1:1000; Sigma, St. Louis, USA). A rabbit polyclonal anti-β actin antibody (1:5000; abcam, 
Cambridge, UK) was used for normalization. 
Primary antibodies were visualized using a horseradish peroxidase-coupled secondary 
antibody (1:30000; Promega, WI, USA) and the ECL detection system (Pierce, Rockford, IL, 
USA).  
 
2.6. Histological Examination and Immunohistochemistry 
For immunohistochemistry of mouse cerebella, animals were perfused with 50 ml of ice-cold 
PBS and the same volume of ice-cold 4% PFA in PBS. The brains were subsequently kept in 
4% PFA for 24 h at 4°C, then washed with PBS, and mounted in 4% agarose (w/v in PBS). 
70 µm sections of the cerebellum were cut on a vibratome (Leica, Bentheim, Germany) and 
blocked with 10% normal goat serum in PBS. The free floating sections were then incubated 
with a polyclonal rabbit anti-annexin A5 antibody (1:100; Hyphen, Biomed, Neuville, France) 
or a polyclonal mouse anti-calbindin antibody (1:2000; Swant, Switzerland) for 1 h at RT. 
Primary antibodies were subsequently detected using fluorescent secondary antibodies (1:800; 
Alexa Fluor 488 or 555, Molecular Probes, Invitrogen, Carlsbad CA, USA). 
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For histological examinations of the reproductive system, ovaries, oviduct, uterus, cervix, and 
vagina or pieces of testicular tissue, epididymides, and efferent ducts respectively were 
dissected, and the tissues were fixed overnight in 4% PFA in PBS at pH 7.2, dehydrated 
through an ethanol series, and embedded in paraffin. Serial sections of 7 µm were prepared 
and stained with haematoxylin and eosin.  
For immunostaining paraffin sections were deparaffinized and rinsed in PBS containing 0.5% 
BSA to reduce nonspecific antibody binding. Endogenous peroxidase activity was blocked 
with 3% hydrogen peroxide in PBS for 10 min. After washing in PBS, sections were 
incubated for 1 h at RT with rabbit-anti-α-smooth muscle actin (1:500; A2547, Sigma, USA 
or RB-9010, Lab Vision, USA) which was subsequently detected with a biotinylated goat 
anti-rabbit IgG (1:800; E0432, Dako, Denmark) as secondary antibody. After the addition of 
streptavidin-coupled horse radish peroxidase, the chromogenic reaction was carried out by 
incubating the sections with the substrate 3,3‘-diaminobenzidine for 5 min; sections were 
rinsed in PBS, dehydrated in ascending ethanol concentrations, coverslipped, and recorded 
with a Zeiss Axiophot photomicroscope. The histological analysis of the female reproductive 
tract was done in collaboration with PD Dr. Ruth Grümmer and Prof. Dr. Elke Winterhager 
from the Department of Anatomy, University Essen, Germany. The histology of the male 
reproductive system was analyzed in collaboration with Dr. Joachim Wistuba and coworkers 
from the Institute of Reproductive Medicine, University of Münster, Germany. 
 
2.7. Dopamine Radioimmuno Assay 
Serum was pooled from 4 animals per genotypes and 300µl were used for radioimmuno assay 
(RIA). At least six pituitaries, adrenals and hypothalami per genotype were pooled, 
homogenized in 100µl of 100mM HEPES buffer pH 7.0; the tissue remnants were separated 
by centrifugation and 50µl of the supernatant were used for RIA and for the determination of 
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protein content. The RIA was carried out according to the instructions of the manufacturer of 
the kit (LDN, Nordhorn, Germany). 
 
2.8. Tyrosine Hydroxylase Activity Assay 
The anterior parts of 5 pituitaries of each genotype were pooled and homogenized in 50µl of 
100mM HEPES pH 7.0. Tyrosine hydroxylase activity was determined using a modified 
method from Thorolfsson et al. (Thorolfsson et al. 2002). Tissue remnants were separated by 
centrifugation and 29 µl of the supernatant were incubated at 30°C in 100 mM HEPES pH 7.0 
containing 1 µM 3H-tyrosine (55 Ci/mmol; Amersham GE Biosciences, UK), 0.5 mg/ml 
catalase (Sigma, Schnelldorf, Germany), 100 µM FeSO4 and 50 µM tetrahydrobiopterin 
(dissolved at 5mM in 500mM DTT; Sigma, Schnelldorf, Germany) in a final volume of 50 µl. 
Aliquots of 9µl were taken after different periods of time (5, 10, 20 and 60 minutes). The 
reaction was stopped by adding 91 µl of a slurry of activated charcoal in 1 M hydrochloric 
acid. The 3H-tyrosine containing charcoal was separated by centrifugation and the 3H-
containing water in the supernatant was quantified by liquid scintillation counting. Activity 
was subsequently normalized according to the total protein content of the samples. 
 
2.9. Hormone Measurements 
Serum hormone levels were measured using competitive immuno assays for estrogen (Bayer 
Diagnostics 06792063, Leverkusen, Germany) and progesterone (Bayer Diagnostics 
01586287, Leverkusen, Germany) in the Department of Anatomy, University of Essen, 
Germany. Serum testosterone was measured by RIA (Chandolia et al. 1991) by the Institute of 
Reproductive Medicine, University of Münster, Germany. 
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2.10. Deiodinase Type II Activity Assay 
Deiodinase type II activity assays were performed by Prof. Dr. Theo Visser (Erasmus Medical 
Center, Rotterdam, The Netherlands) as already described (Friedrichsen et al. 2003).  
 
2.11. Statistical Analysis 
For statistical analysis the Students’ ttest was applied. If not stated otherwise, results are 
presented as mean ± standard deviation (SD) and the following p-values were considered 
significant and marked accordingly: p<0.05 *, p<0.005 ** and p<0.001 ***. 
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3. Results 
3.1. Generation and Analysis of Pax8-/-TRα1-/- Double Mutant Mice 
3.1.1. Development of Pax8-/-TRα1-/- Animals 
Pax8-/-TRα1-/- mice were generated by intercrossing Pax8+/- (Mansouri et al. 1998) and 
TRα1-/- mice (Wikström et al. 1998). Female and male Pax8+/-TRα1-/- mice showed normal 
fertility and the litter size was unaffected. Like Pax8-/- mice, most Pax8-/-TRα1-/- mice were 
born with a lower body weight compared to their littermates. Postnatal growth of Pax8-/-
TRα1-/- mice was clearly retarded (Fig. 3.1) compared to Pax8+/-TRα1-/- and TRα1-/- animals 
that developed more slowly than wildtype controls. 
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Fig. 3.1: Postnatal development of Pax8-/-TRα1-/- double mutant mice in comparison with Pax8-/- mice and 
controls. 
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Most of the double mutant mice died during the first 2 postnatal weeks and only about one 
fourth reached the weaning age of 21 days. Even when the litter size was reduced to 4 pups 
directly after birth, Pax8-/-TRα1-/- mice did not survive weaning. By daily administration of 
T4 from P2 onwards, Pax8-/-TRα1-/- mice could be rescued and survived to adulthood, 
indicating that the mortality of these animals is a direct consequence of their athyroidism.  
Survival of athyroid mutant mice (Pax8-/-TRα1-/- and Pax8-/-) could also be achieved by 
keeping these mice under a lactating dam for additional 15 days until P36, indicating that a 
retarded intestinal development might be responsible for the death around weaning when the 
food situation is changed. By the age of P36 the intestine seems to be readily developed to 
digest the normal food and the animals can reach adulthood despite their athyroidism. 
 
3.1.2. Serum Thyroid Hormone Levels 
Total T3 and T4 are undetectable in serum of Pax8-/- and Pax8-/-TRα1-/- animals, confirming 
that maternal supply is negligible after birth. In Pax8+/-TRα1-/- animals, total T4 was slightly 
reduced in both genders, while T3 serum levels were slightly increased (Table 3.1), with the 
consequence that the T3/T4 ratio was also increased in these animals. 
 
Table 3.1: Thyroid hormone serum levels and T3/T4 ratio in Pax8+/-TRα1-/- animals and controls. The athyroid 
mutants Pax8-/-TRα1+/+ and Pax8-/-TRα1-/- did not show detectable serum levels of T3 or T4.  Values are 
indicated as mean ± SD. *: p<0.01; **: p<0.05 and ***: p<0.001. 
 
In good agreement with the increased T3/T4 ratio D1 liver activity was higher in Pax8+/-
TRα1-/- mice (17.19 ± 3.41 pmol/min·mg) compared to controls (10.63 ± 6.53 pmol/min·mg; 
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p<0.05), whereas no significant difference was observed in the athyroid mouse models (0.99 
± 0.33 pmol/min·mg in Pax8-/- compared to 0.91 ± 0.21 pmol/min·mg in Pax8-/-TRα1-/-). 
 
3.1.3. Tissue Weight Analysis 
As an initial characterization of the Pax8-/-TRα1-/- mice, tissue weights were analyzed at P21. 
When normalized to the corresponding body weights, organ weights differed quite 
remarkably between the different mutants (Fig. 3.2). 
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Fig. 3.2: Tissue weights of the different mutant mice after normalization relative to their body weight. 
(*: p<0.05; **: p<0.005; ***: p<0.001) 
 
In Pax8-/- and Pax8-/-TRα1-/- mice, relative organ weights of lung and pituitary were increased, 
whereas the weights of spleen, stomach and kidney were decreased compared to controls and 
TRα1-/- animals. Tissue weights of Pax8-/-TRα1-/- mice closely resembled those of Pax8-/- 
animals with one exception: in all mutant mice analyzed, relative brain weight was found to 
be elevated compared to control animals with the highest weight observed in Pax8-/-TRα1-/- 
mice (a 1.6-fold increase compared to Pax8-/- mice). Even when absolute brain weights were 
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considered, the relatively small Pax8-/-TRα1-/- animals (4.2 g) had a slightly larger brain 
(0.425 ± 0.047 g) relative to control animals (0.336 ± 0.017 g) with a body weight of 11.1 g.  
While all organs analyzed appeared macroscopically normal, the pituitaries of the athyroid 
Pax8-/- and Pax8-/-TRα1-/- mice exhibited a glossy/translucent and not an opalescent 
appearance like those of control and TRα1-/- animals (Fig. 3.3). 
A
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Fig. 3.3: Macroscopical appearance of pituitaries from wildtype (A), Pax8-/- (B), TRα1-/- (C) and Pax8-/-TRα1-/- 
double mutant mice (D). Scale bar 2mm. 
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3.1.4. Expression Pattern Analysis of Pituitary Hormones  
Analysis of pituitary hormone expression by in situ hybridization revealed no differences 
between control and TRα1-/- mice, neither with regard to the signal intensities nor with regard 
to the cellular distribution pattern (Fig. 3.4).  
 
Fig. 3.4: mRNA expression of the pituitary hormones in the different mutant mice as analyzed by in situ 
hybridization histochemistry. Scale bar 500µm. 
 
In contrast, the cellular composition of the athyroid Pax8-/- and Pax8-/-TRα1-/- mice pituitaries 
was completely deranged. Not only the β-TSH transcript levels but also the number of cells 
expressing β-TSH mRNA were dramatically increased in both animal models. Lactotrophs 
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were almost absent in these mice and the numbers of GH and LH mRNA expressing cells 
were decreased. Only corticotrophs appeared not to be affected by the absence of TH. 
Quantitative Real-Time PCR analysis revealed that corresponding to the ISH, β-TSH 
transcript levels were highly increased whereas prolactin and GH levels were dramatically 
decreased in the athyroid animals (Fig. 3.5).  
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Fig. 3.5: mRNA levels of pituitary genes in the different mutant mice as analyzed by Real-Time PCR. 
 
No obvious changes in transcript levels were observed in the pituitaries of TRα1-/- mice 
compared to wildtype controls. Again, the Pax8-/-TRα1-/- pituitary phenotype closely 
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resembled that of Pax8-/- animals implying that TRα1 aporeceptor activity is not responsible 
for the malformation of the pituitary as observed in Pax8-/- mice. 
We further employed quantitative Real-Time PCR to assess the transcript levels of the T3 
binding TR isoforms. Compared to control animals, TRα1 mRNA levels were not different in 
Pax8-/- mice. TRβ transcript levels were also quite similar in all four genotypes. 
 
3.1.5. Deiodinase Type II in the Pituitary 
In the pituitary, expression of deiodinase type II is known to be negatively regulated by TH 
and critically involved in mediating the effect of TH on pituitary gene expression. Therefore 
the regulation and the localization of this enzyme were also analyzed. While D2 mRNA 
expression could be detected in the thyrotrophic cells by colocalization with TSH mRNA, 
none of the other endocrine celltypes like somatotrophs, corticotrophs, lactotrophs or 
gonadotrophs expressed D2 (Fig. 3.6). When quantified, 99% of cells expressing TSH also 
expressed D2 mRNA, whereas 43% of the D2 positive cells were not positive for TSH, 
indicating that a subpopulation of non-endocrine cells (probably folliculo-stellate cells) also 
expressed D2 mRNA. 
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Fig. 3.6: Colocalization of D2 mRNA with hormonal mRNA expression. The left panel shows the mRNA 
expression pattern of the hormones GH, LH, POMC, prolactin and TSH as assessed by in situ hybridization 
histochemistry with DIG labeled probes. The middle panel shows the corresponding D2 mRNA expression as 
analyzed by in situ hybridization with radioactively labeled probes and visualized under darkfield illumination. 
The arrows indicate identical structures in the TSH and D2 mRNA expression patterns. The right panel shows 
single cells at higher magnification, either expressing D2 mRNA (white grains) or hormonal mRNA (black 
spots). Scale bar left panels 200µm, scale bar right panel 20µm. 
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The regulation of D2 by TRα1 was also analyzed. Real-Time PCR was used to determine the 
mRNA expression levels, whereas enzymatic activity was analyzed by the turnover of 
radioactively labeled thyroxine (Fig. 3.7). 
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Fig. 3.7: Deiodinase type II mRNA levels as analyzed by Real-Time PCR and the enzyme activity in pituitaries 
of the different mutant mice. (*: p<0.05) 
 
While no significant difference was observed between wildtype and TRα1-/- animals neither in 
mRNA expression nor in enzyme activity, D2 mRNA levels were upregulated in athyroid 
Pax8-/- mice as expected. Surprisingly this upregulation of D2 mRNA was abolished in Pax8-/-
TRα1-/- double mutant mice. Since D2 activity is posttranslationally negatively regulated by a 
non-genomic effect of T4, D2 enzyme activity was higher in these mice when compared to 
wildtype and TRα1-/- animals, although mRNA levels were not different. However, D2 
enzyme activity was still significantly reduced in Pax8-/-TRα1-/- animals when compared to 
Pax8-/- mice, indicating that the posttranslational regulatory mechanism cannot fully 
compensate for the reduction of D2 mRNA levels in the double mutants. 
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3.2. Identification of Thyroid Hormone Regulated Factors in the Pituitary 
3.2.1. Prolactin mRNA Expression and Lactotroph Development in Pax8-/- Mice 
As already described, Pax8 deficient animals exhibit a reduced mRNA expression of prolactin 
as well as a dramatically reduced number of lactotrophs in the anterior pituitary (Friedrichsen 
et al. 2004). TH replacement therapy from P3 until P21 restores these deficits as analyzed by 
ISH, indicating that both effects are a direct consequence of the athyroid conditions in Pax8 
null mice (Fig. 3.8). The reduction in the lactotrophic cell population was additionally 
confirmed using radioactive labeled probes for dopamine receptor 2 which is exclusively 
expressed on these cells (Inoue et al. 1999). 
 
Fig. 3.8: In situ hybridization showing the mRNA expression of prolactin (PRL) and dopamine receptor 2 (D2R) 
in wildtype (WT), untreated and T4 treated Pax8-/- mice. Scale bar 500µm. 
 
In good agreement with previous observations (Friedrichsen et al. 2004), a complete 
restoration of the lactotroph population requires treatment with TH from P3-21 (Fig. 3.8), 
while prolactin mRNA expression in the remaining lactotrophs is already restored after a 3 
day administration of physiological TH doses (Fig. 3.9C) (Friedrichsen et al. 2004).  
To analyze postnatal lactotroph development in Pax8 null mice in more detail, these animals 
were injected at the age of 3, 6 and 12 weeks for 3 consecutive days with physiological doses 
of TH to increase the prolactin mRNA to a detectable level. Animals at 6 and 12 week of age 
Results 
 27
were obtained by prolonged weaning as described above (see 3.1.1) and were thus completely 
athyroid during postnatal life until the injections. Lactotroph distribution was then analyzed 
by ISH for prolactin mRNA (Fig. 3.9). 
 
Fig. 3.9: In situ hybridization for prolactin mRNA in P21 wildtype (A) and Pax8 null (B) mice as well as Pax8 
deficient animals at the age of 3 (C), 6 (D) and 12 (E) weeks which were treated for 3 days with physiological 
doses of TH. Scale bar 500µm. 
 
As expected, prolactin mRNA expression was not detectable in untreated Pax8-/- mice (Fig. 
3.9B) and even after treating these animals with T4 for 3 days, only few lactotrophs were 
observed (Fig. 3.9C). In Pax8 deficient animals at 6 weeks of age that were also treated with 
T4 for 3 days (Fig. 3.9D), the number of lactotrophs was already increased compared to the 
Pax8 null mice at 3 weeks of age. At 12 weeks of age, the number of lactotrophs was further 
increased (Fig. 3.9E) reaching almost the level of wildtype mice at 3 weeks of age (Fig. 
3.9A). This result suggests that under athyroid conditions the development of lactotrophs is 
not completely abolished but only delayed. Untreated Pax8 null mice throughout all ages did 
not show any detectable prolactin mRNA (data not shown). 
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3.2.2. Differential Gene Expression in Pituitaries of Pax8 Deficient Animals  
In order to identify factors that are regulated by TH and might be involved in modulating 
prolactin mRNA expression or lactotroph development by auto- or paracrine mechanisms, the 
mRNA expression profile of pituitaries from wildtype and Pax8 deficient animals was 
analyzed using the Affymetrix Gene Chip 430A. The comparison was done in duplicates with 
the Affymetrix Micorarray Analysis Software and revealed that the expression level of 11.3% 
of all genes analyzed was significantly changed. In average 5.6% of the genes were down- 
and 5.7% were upregulated in Pax8-/- mice.  
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Fig. 3.10: Scatterplot showing the expression levels of >34.000 genes in pituitaries of wildtype and Pax8 
deficient mice. Green lines indicate a 2, 3, 5 and 10-fold change in gene expression between wildtype and mutant 
mice. Gene expression was considered absent when mRNA levels were not significantly above background. Red 
spots mark genes that were expressed in both genotypes, green spots indicate genes only expressed in the 
wildtype, black spots symbolize genes only expressed in pituitaries of Pax8 null mice and yellow spots mark 
genes that were not significantly expressed in mouse pituitaries. 
 
Many of the genes with significant changes in both arrays were either of unknown function 
such as some RIKEN cDNA clones, or the expression of these genes was already known to be 
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changed in pituitaries of Pax8 null mice such as the genes encoding β-TSH, TRH-R1, GH, 
PRL, β-FSH, β-LH or dopamine receptor 2. Due to the limitations of a PhD thesis, it was 
impossible to validate all genes differentially expressed in the pituitary of Pax8 deficient 
animals. Thus, eight genes which were considered to be of biological significance in the 
context of this study were chosen for further investigation (Table 3.2). 
1st experiment 2nd experiment mean
mRNA
wildtype
mRNA
Pax8-/-
mRNA
wildtype
mRNA
Pax8-/-
change
-fold
error
(SD)
gene name
69,1 A 361 P 103,8 A 574,6 P 5,4 0,2 Calcitonin Gene Related Peptide α
465,1 P 2831,1 P 75 A 4723,8 P 35 28,4 Annexin A10 (Spot 1)
4,5 A 139,3 P 1,9 A 238,7 P 78 47,3 Annexin A10 (Spot 2)
431,1 P 883 P 616,9 P 1174,7 P 2 0,1 Annexin A1
10837 P 7884,1 P 11449,7 P 4719,8 P 0,6 0,2 Annexin A5
358,1 P 4553,7 P 182,6 A 2983,5 P 15 1,8 Tyrosine Hydroxylase
978 P 1226,4 P 591,3 P 2087,3 P 2,4 1,1 Neuromedin B
308,1 P 2414,5 P 219,8 A 1225,2 P 6,7 1,1 Calsequestrin 2
44,5 A 876,3 P 196,9 A 1308,9 P 13 6,5 Calbindin 2
899 P 617,1 P 1346,4 P 607,3 P 0,6 0,1 STAT 1
167,4 P 552,5 P 17,9 A 638,2 P 19,5 16,2 STAT 4
 
Table 3.2: Differentially regulated genes that were chosen for further analysis (values show the relative 
expression level in arbitrary units after normalization with the overall signal intensity; A: absent, P: present). 
 
 
 
 
3.2.3. Validation of Differential mRNA Expression by In Situ Hybridization 
To confirm the results from the microarray analysis, cDNA fragments of the candidate genes 
were cloned and subsequently used for the generation of ISH probes. While mRNA 
expression of calcitonin-gene related peptide and neuromedin B could not be detected by this 
technique, mRNA expression of the other genes was in good agreement with the microarray 
data revealing an upregulation of Annexin A1, A10, tyrosine hydroxylase, STAT4, calbindin 
2 and calsequestrin 2 as well as a downregulation of Annexin A5 and STAT1 in athyroid 
Pax8 null mice (Fig. 3.11). 
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Fig. 3.11: Validation of the microarray data by in situ hybridization histochemistry showing the mRNA 
expression of chosen candidate genes in pituitaries of wildtype and Pax8 deficient mice. Scale bar 500µm. 
 
3.2.4. Tyrosine Hydroxylase as a Potential Candidate for Lactotroph Inhibition 
Since dopamine is the decisive factor in the control of lactotroph proliferation and prolactin 
secretion (Ben-Jonathan et al. 2001), tyrosine hydroxylase seemed to be the most promising 
candidate among these genes, because this enzyme catalyzes the committed step in dopamine 
synthesis (Kumer et al. 1996).  
The increase of tyrosine hydroxylase mRNA in anterior pituitaries of Pax8 null mice was 
additionally confirmed by quantitative Real-Time PCR revealing a 20-fold increase at the 
mRNA level, whereas mRNA expression of dopa decarboxylase, the second enzyme 
necessary for dopamine synthesis, was not increased. No transcripts were detected for 
enzymes that are required for the production of epinephrine from dopamine like dopamine-β-
hydroxylase or phenylethanolamine-N-methyl-transferase (PNMT) (data not shown).  
To analyze whether tyrosine hydroxylase is indeed expressed at the protein level, a western 
blot analysis was performed. While in pituitaries of wildtype mice only a faint band of 
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tyrosine hydroxylase was detected by this technique, athyroid Pax8 deficient animals revealed 
a distinct band of this protein (Fig. 3.12A). To confirm the enzymatic activity of the tyrosine 
hydroxylase protein, an activity assay was performed by measuring the in vitro conversion of 
3H-labeled tyrosine (Fig. 3.12B). The results demonstrated that pituitaries of Pax8-/- but not of 
wildtype mice had the capacity to actively synthesize dopamine. 
 
Fig. 3.12: Analysis of tyrosine hydroxylase protein content in the anterior pituitary by Western Blot analysis (A) 
and enzymatic activity assay (B). The analysis revealed an increased amount of enzymatically active tyrosine 
hydroxylase under athyroid conditions. The dopamine levels in pituitary, hypothalamus, adrenals and serum 
were then determined by radioimmuno assay (C). (*:p<0.05; ***:p<0.001; ns: not significant) 
 
The analysis of the dopamine content by radioimmuno assay revealed an increased dopamine 
content in anterior pituitaries of Pax8-/- mice (Fig. 3.12C), indicating that the increase of 
tyrosine hydroxylase in this tissue indeed lead to higher dopamine synthesis. An increase of 
dopamine in the serum and the adrenals of Pax8 null mice was also detected, which is not 
easily explained. 
The dopamine content in the hypothalamus was not different in Pax8 deficient animals 
compared to wildtype controls, which is in good agreement with an unaltered tyrosine 
hydroxylase mRNA expression in hypothalamic areas of these mice as assessed by ISH (Fig. 
3.13A), indicating that the hypothalamus is not the cause for the higher dopamine content in 
the pituitary. 
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Fig. 3.13: Tyrosine hydroxylase mRNA expression in the hypothalamus of wildtype (WT) and Pax8 deficient 
animals (A) as assessed by radioactive in situ hybridization (ME: median eminence, 3V: 3rd ventricle). In 
anterior pituitaries of Pax8 null mice (B), radioactively labeled probes for tyrosine hydroxylase (TyH) mRNA 
colocalize with DIG-labeled probes for β-thyroid stimulating hormone (TSH) as analyzed by double in situ 
hybridisation (white arrows indicate identical cells).  
 
To identify the cellular localization of tyrosine hydroxylase in the anterior pituitary, a 
colocalization study was performed by double ISH with radioactively labeled probes for 
tyrosine hydroxylase and DIG-labeled probes for β-TSH. As shown in Fig. 3.13B, most of the 
thyrotrophic cells also express tyrosine hydroxylase mRNA. 
To confirm the regulation of tyrosine hydroxylase mRNA expression by TH, P18 Pax8-/- mice 
were treated with physiological doses of thyroxine for 3 days. This treatment lead to an 
almost complete reduction of tyrosine hydroxylase mRNA expression and to the mRNA 
expression of prolactin in a few cells (Fig. 3.14), suggesting that the reduction of tyrosine 
hydroxylase causes decreased dopamine production. 
Results 
 33
 
Fig. 3.14: Rapid regulation of tyrosine hydroxylase mRNA expression by TH. After a 3 day treatment of Pax8 
deficient mice with physiological doses of T4, tyrosine hydroxylase mRNA was drastically reduced and 
prolactin transcripts (PRL) were detected in a few lactotrophs only. Scale bar 500µm. 
 
To investigate whether the increased local dopamine production in the anterior pituitary of 
athyroid mice is responsible for the retardation in lactotroph development and the reduction of 
prolactin mRNA expression, Pax8-/- mice were treated with the dopamine antagonist 
haloperidol from P3 until P21 to abolish dopamine action (Fig. 3.15B). As revealed by ISH, 
prolactin mRNA expression was only detectable in a few cells and the number of lactotrophs 
was still dramatically reduced compared to wildtype controls (Fig. 3.15A).  
 
 
Fig. 3.15: In situ hybridization histochemistry showing prolactin mRNA expression in pituitaries of wildtype 
(WT), bromocryptine treated wildtype and haloperidol treated Pax8 deficient animals. Scale bar 500µm. 
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Conversely, to mimic the high dopamine levels in Pax8 deficient animals, wildtype mice were 
treated with the dopamine agonist bromocryptine from P2 until P21 and analyzed at P21. 
Pituitaries of these mice did not show any detectable prolactin mRNA expression (Fig. 
3.15D), indicating that the bromocryptine treatment was carried out properly. Subsequently, 
wildtype mice were treated with bromocryptine from P2 until P18 and the pituitaries were 
analyzed at P21. ISH revealed that prolactin transcript levels were almost normalized in these 
mice within three days. Surprisingly, the number of lactotrophs was not affected (Fig. 3.15C), 
which suggests, that lactotroph development cannot be blocked by this dopamine agonist.  
Since hypothyroidism is known to induce hyperprolactinemia in adult humans, the situation in 
adult hypothyroid mice was also analyzed. For this, Pax8 deficient animals were treated from 
P2 onwards with T4 for 40 days and then left without treatment for 10 or 40 days to render 
them hypothyroid again. The hypothyroidism was confirmed by an upregulation of β-TSH as 
analyzed by ISH (Fig. 3.16A-C). 
As expected, this experimental manipulation caused an increased prolactin mRNA expression 
in these animals (Fig 3.16D-F). Interestingly, tyrosine hydroxylase mRNA was also increased 
in the hypothyroid animals (Fig. 3.16G-I), indicating that the dopamine production of the 
thyrotrophs is not sufficient to reduce prolactin transcript levels effectively in these mice. 
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Fig. 3.16: In situ hybridization showing the mRNA expression of β-TSH, prolactin (PRL) and tyrosine 
hydroxylase (TyH) in pituitaries of wildtype mice at 80 days of age and Pax8 deficient animals that were treated 
with thyroxine for 40 days and the left without treatment for 10 or 40 days respectively. Scale bar 500µm. 
 
In addition, untreated Pax8 null mice at 6 months of age were also analyzed with regard to 
their prolactin mRNA expression. These mice were obtained by prolonged weaning as 
described above (see 3.1.1). Without T4 treatment mRNA expression of prolactin was very 
low in these mice (Fig. 3.17E), while TSH mRNA was drastically upregulated (Fig. 3.17A) 
and GH mRNA levels were strongly decreased (Fig. 3.17J). As expected, TSH as well as GH 
mRNA expression were effectively increased by treatment of Pax8 deficient animals with T4 
for 4 days (Fig. 3.17B and K), but not when Pax8-/- mice were treated with haloperidol for 4 
weeks (Fig. 3.17C and L). In contrast, prolactin mRNA expression was increased in these 
mice after thyroxine or haloperidol treatment (Fig. 3.17F, G and H), indicating that dopamine 
inhibits prolactin mRNA expression in a thyroid hormone dependent manner. 
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Fig. 3.17: In situ hybridization analysis showing mRNA expression of β-TSH, prolactin (PRL), growth hormone 
(GH) and tyrosine hydroxylase (TyH) in pituitaries of 6-months-old untreated Pax8-/- mice and Pax8-/- animals 
that were treated with T4 or haloperidol for the indicated period of time. Scale bar 500µm. 
 
Since an increased stimulation of lactotrophic cells by upregulated hypothalamic TRH is one 
cause for hyperprolactinemia in humans under hypothyroid conditions (Ceccatelli et al. 1992), 
TRH-R1-/-Pax8-/- double knockout mice were generated by intercrossing TRH-R1-/- (Rabeler 
et al. 2004) and Pax8+/- mice (Mansouri et al. 1998).  
As in the experiment above, these double mutant mice were injected from P2 onwards with 
T4 for 40 days and then left without treatment for additional 40 days to render them 
hypothyroid. As in Pax8 deficient mice (Fig. 3.16C), TSH mRNA expression levels were 
highly increased in pituitaries of TRH-R1-/-Pax8-/- double mutants with thyrotrophs exhibiting 
clear signs of hyperplasia and hypertrophy (Fig. 3.18D). Since the hypothalamic signal TRH 
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cannot be transmitted to the pituitary in TRH-R1 deficient animals, this result strongly 
indicates that the distorted condition of the thyrotrophs in athyroid mice is not caused by an 
overstimulation of the thyrotrophs via TRH but rather by the lack of the negative feedback 
through TH. 
 
Fig. 3.18: In situ hybridization analysis showing mRNA transcript levels of β-TSH, prolactin (PRL) and tyrosine 
hydroxylase (TyH) in adult TRH-R1 deficient animals and TRH-R1-/-Pax8-/- double mutant mice that were 
treated with thyroxine for 40 days and then kept without treatment for additional 40 days. Scale bar 500µm. 
 
Compared to TRH-R1 deficient controls (Fig. 3.18C), prolactin mRNA expression was not 
affected in the experimentally manipulated TRH-R1-/-Pax8-/-double mutant mice (Fig. 3.18D) 
suggesting that the increased prolactin mRNA levels in hypothyroid adult Pax8 deficient mice 
(Fig. 3.16F) were indeed caused by an increased TRH stimulus. As expected, tyrosine 
hydroxylase mRNA was also increased in the TRH-R1-/-Pax8-/- double mutants (Fig. 3.18F). 
Most interestingly, the observed increase in tyrosine hydroxylase did not lead to a suppression 
of prolactin mRNA expression in these mice in contrast to the situation in Pax8-/- animals at 3 
weeks of age, which did not show significant expression of prolactin mRNA (Fig. 3.9B, p.27). 
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3.2.5. Role of Annexin A5 in the Anterior Pituitary 
To investigate the role of annexin A5, another candidate gene found to be upregulated in the 
pituitaries of Pax8 deficient mice, annexin A5 deficient animals were analyzed with regard to 
their mRNA expression of the pituitary hormones by ISH (Fig. 3.19). 
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Fig. 3.19: In situ hybridization analysis showing the mRNA expression of β-TSH, growth hormone (GH), 
prolactin (PRL), β-LH, β-FSH and proopiomelanocortin (POMC) in pituitaries of wildtype (A5+/+), heterozygous 
(A5+/-) and annexin A5 deficient mice (A5-/-). Scale bar 500µm. 
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The analysis by ISH revealed no obvious differences neither with regard to the number of 
cells expressing β-TSH, GH, prolactin, or POMC transcripts, nor with regard to the signal 
intensity. The mRNA expression of β-LH and β-FSH showed a slight reduction in the number 
of cells expressing these hormones in the A5 deficient animals. To further quantify this 
observation, quantitative Real-Time PCR was used (Fig. 3.20), which showed a minor but 
significant reduction by half of β-FSH mRNA levels in the pituitaries of A5-/- mice. Transcript 
levels of all other hormones were not significantly changed in A5 deficient mice. 
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Fig. 3.20: mRNA expression of the pituitary hormones β-TSH, growth hormone (GH), prolactin (PRL), β-LH 
and β-FSH in wildtype (A5+/+) and annexin A5 deficient animals (A5-/-) as analyzed by quantitative Real-Time 
PCR. (*:p<0.05) 
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3.3. Analysis of the Infertility in T4-Treated Pax8-/- Mice 
3.3.1. T4-Substituted Pax8-/- Mice Are Infertile 
As a consequence of their athyroidism, Pax8-/- mice die around weaning time and therefore 
they can only be obtained by mating heterozygous Pax8+/- animals. In the attempt to 
overcome this disadvantage and to set up homozygous breeder pairs, congenital hypothyroid 
Pax8-/- mice were treated with T4 from P2 onwards in the expectation that they will survive to 
adulthood and become fertile, since TH replacement therapy generally restores the deficits 
observed in CH (Friedrichsen et al. 2004, Christ et al. 2004). Although T4-treated Pax8-/- 
animals of both genders developed similarly to wildtype littermates, they did not reproduce 
when caged together with fertile wildtype mice of the opposite gender. 
 
3.3.2. Expression of Pituitary Hormones in T4-Substituted Pax8-/- Mice 
Untreated Pax8-/- mice exhibit a dramatically distorted cellular composition of the anterior 
pituitary with hypertrophy and hyperplasia of the thyrotrophs, an almost complete absence of 
lactotrophs and a drastically reduced number of somatotrophs (Friedrichsen 2004). Therefore 
the mRNA expression of β-TSH, prolactin, GH, β-LH, β-FSH and POMC was analyzed by 
ISH in T4-substituted Pax8-/- mice of both genders in order to assess whether their infertility 
might be caused by an impaired expression of these hormones. Compared to wildtype 
littermates, no obvious differences neither in the mRNA expression of the hormones analyzed 
nor in the cellular composition of the gland were found in T4-treated Pax8-/- mice (Fig. 3.21). 
This was even true for the expression of β-TSH which is tightly controlled by negative 
feedback of TH, thus illustrating the euthyroid status of the T4-substituted animals. 
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Fig. 3.21: In situ hybridization analysis showing the mRNA expression of β-TSH, prolactin (PRL), growth 
hormone (GH), β-LH, β-FSH and proopiomelanocortin (POMC) in pituitaries of wildtype (WT), Pax8-/- and T4- 
treated Pax8-/- mice of both genders. Scale bar 500µm. 
 
3.3.3. Initial Analysis of the Male Reproductive System 
As expected from the normal gonadotropin mRNA expression in T4-treated male Pax8-/- 
mice, serum and intratesticular testosterone levels, although quite variable, were not 
significantly different between all groups of adult animals (Fig. 3.22A and B). 
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Fig. 3.22: Serum (A) and intratesticular testosterone levels (B) in wildtype (WT) and T4-treated Pax8-/- mice as 
determined by radioimmuno assay. 
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The body weight as well as the weight of the epididymides and the accessory sex glands of 
adult T4-treated Pax8-/- males were not different when compared to control animals, but testis 
weight exhibited a significant reduction by 35% (Fig. 3.23). 
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Fig. 3.23: Body weight and weight of the epididymis, accessory sex glands (ASGl) and the testis of wildtype and 
T4-treated adult Pax8-/- male mice. (*:p<0.05) 
 
3.3.4. Histology of the Testis and Quantification of Spermatogenesis 
To investigate the testicular phenotype, cross sections of the testis were analyzed 
histologically. Wildtype controls showed qualitatively normal spermatogenesis in the 
testicular cross-sections with elongated spermatids in almost all tubules (Fig. 3.24A). In 
contrast, testis from T4-treated Pax8 deficient animals revealed focally atrophic regions with 
tubules showing arrested spermatogenesis and a variable degree of disorganization (Fig. 
3.24B). 
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Fig. 3.24: Haematoxylin stained cross-sections through testis of wildtype (A) and thyroxine treated Pax8-/- mice 
(B). Scale bar 50µm. Quantification of the testicular spermatogenesis in these mice revealed a high degree of 
disorganization in T4-treated Pax8 deficient animals (C). (SCO: Sertoli Cells Only; spg: spermatogonial; sptc: 
spermatocytes; rsptd: round spermatids; El sptd: elongated spermatids). 
 
Subsequent quantification of the spermatogenic progress revealed an increased number of 
tubules with an arrest of the spermatogenic process at the level of spermatocytes or round 
spermatids in T4-treated Pax8 deficient mice, while the number of tubules containing 
elongated spermatids as the most advanced germ cell type was decreased compared to 
wildtype controls (Fig. 3.24C). 
 
3.3.5. Analysis of the Epididymis and the Efferent Duct  
Whereas in wildtype animals the epididymal lumen was full of spermatozoa, the epididymis 
of adult T4-treated Pax8-/- mice did not contain any sperm (Fig. 3.25A). One out of the three 
Pax8 deficient mice analyzed showed unilateral absence of the efferent ducts and the 
epididymis up to the vas deferens.  
An abnormality in epithelial development was observed in the proximal corpus of the 
epididymis where the epithelium in Pax8 null mice was taller than in other regions and in the 
same region of the wildtype. In the more distal regions, especially in the cauda, large vacuoles 
were frequently found in the epithelium of the Pax8 null mice (Fig. 3.25A; arrows).  
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Fig. 3.25: Cross-sections through the epididymis (A) and efferent ducts (B and C) of wildtype (WT) and T4-
treated Pax8-/- mice. The white arrows indicate the large vacuoles found in the epididymal epithelium of T4-
treated Pax8 null animals. Scale bars 50µm. 
 
Histological examination of the efferent ducts revealed a narrowed lumen in Pax8-/- animals 
with more extensive connective tissue between the tubules (Fig. 3.25B). Additionally, 
dilations of the efferent ducts sometimes with extremely large lumen and flattened low 
epithelium were observed in T4-treated Pax8 deficient animals (Fig. 3.25C). 
To obtain additional insights for an involvement of TH signalling in reproductive functions, 
TRα1-/-TRβ-/- mice were also analyzed with regard to their fertility. Histological analysis 
revealed no differences when the reproductive system was compared with wildtype mice; the 
epididymal tubules were full of spermatozoa and those matured and stored in the cauda of the 
epididymis showed the same percentage of motility in both phenotypes. Detailed 
measurement of sperm kinematics using computerized analysis (Yeung et al. 2002) revealed a 
slight but significant decrease in the swimming velocities of the spermatozoa from TRα1-/-
TRβ-/- double mutants (Table 3.3).  
Results 
 45
 
 
WT              TRα1-/-TRβ-/-
% Motility 43.3 ± 4.2 43.9 ± 6.9
VCL (µm/s) 141 ± 2 124 ± 2              * 
VAP (µm/s) 93.6 ± 6 71.3 ± 3              *
VSL (µm/s) 80.7 ± 13.6 57.6 ± 5.1 
LIN (%) 59.2 ± 10.1 46.1 ± 3.1 
ALH (µm)   9.1 ± 1.4 8.1 ± 0.3 
 
 
Table 3.3: Motility analysis of mature spermatozoa from the cauda epididymidis of wildtype and TRα1-/-TRβ-/- 
double mutant mice. The following kinematic parameters were measured: curvilinear (VCL), averaged path 
(VAP) and straight-line (VSL) velocities, linearity of swim-path (LIN) and amplitude of lateral head 
displacement (ALH). Values are mean ± SEM. (*:p<0.05) 
 
The presence of motile sperm in the epididymis of TRα1-/-TRβ-/- double mutant mice indicates 
that the defects observed in male Pax8 deficient animals are not related to disturbances in TH 
metabolism. 
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3.3.6. Ovarian Histomorphology and Steroid Production 
T4-substituted female Pax8-/- mice exhibited normal ovarian morphology as shown by the 
presence of different stages of follicle development similar to wildtype controls (Fig. 3.26A). 
Besides mature follicles, corpora rubra and corpora lutea could also be seen (data not shown) 
giving proof of ovulation. Serum hormone levels of 17β-estrogen and progesterone did not 
show any significant difference in adult T4-substituted Pax8-/- mice when compared to 
wildtype controls (Fig. 3.26B). 
 
 
Fig. 3.26: Ovarian morphology of wildtype and thyroxine treated Pax8-/- mice in (A), serum levels of estradiol 
and progesterone in (B). Scale bar 300µm. 
 
3.3.7. Evaluation of the Female Reproductive Tract 
T4-substituted Pax8-/- mice at seven weeks as well as at six months of age exhibited a vagina 
closed by a lucent membrane (Fig. 3.27A). Following laparatomy, ovarian gross morphology 
was inconspicuous, but the two uterine horns were absent. Instead, only a very thin ligament 
could be seen. An obvious manifestation of a dilated, fluid-filled fallopian tube, a so-called 
hydrosalpinx, had developed in 75% of mice at seven weeks and in 85% of mice at six 
months after birth (Fig. 3.27A). 
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Fig. 3.27: Histology of the female reproductive tract of wildtype and thyroxine treated Pax8-/- mice analyzed 
macroscopically (A), showing the closed vaginal opening (arrow, upper panel), the ligament-like uterus (Ut) and 
the hydrosalpinx in Pax8 deficient animals (HS, lower panel). Microscopic inspection (B) shows a wildtype 
uterus compared with the small tissue remnants of Pax8 deficient mice in (B-1); these tissue residues exhibited 
the histological appearance of smooth muscle cells (Sm) which could be confirmed by staining for α-smooth 
muscle actin (B-2). (B-3) shows a normal fallopian tube of T4-substituted Pax8-/- mice and segments dilated by a 
hydrosalpinx revealing a flattened mucosal layer. (B-4) shows sections of the cervix and the vagina in T4-treated 
Pax8-/- mice (Scale bar in B1, B4 right: 400 µm; in B2: 150 µm; in B3: 300 µm; in B4 left: 125 µm). 
 
The lack of a normal uterus in T4-substituted Pax8-/- mice was confirmed by histological 
examination which revealed only small remnants of ligament-like tissue surrounded by fat 
(Fig. 3.27B-1). These ligaments considerably differed in size compared to wildtype mice. 
Histologically, this residual tissue revealed the morphology of smooth muscle cells which 
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could be confirmed by staining for α-smooth muscle actin, pointing to a myometrial origin. 
The endometrial compartment and the formation of a lumen were missing (Fig. 3.27B-2). 
In contrast to the uterus, the oviduct of T4-treated Pax8-/- mice appeared macroscopically 
normal and revealed no obvious differences compared to wildtype mice (Fig. 3.27B-3 left), 
except those segments which were dilated by the hydrosalpinx (Fig. 3.27B-3 right). Here, an 
extended fluid filled lumen lined by a flattened mucosal layer was observed. Interestingly, the 
cervices were normally developed showing the typical wall morphology of this organ. Due to 
the lack of the natural outflow of secreted fluid via the vaginal opening, however, dilated 
fluid-filled lumina could be observed also in the cervix (Fig. 3.27B-4 left). The vagina itself 
had developed normally showing an appropriate differentiation into a squamous epithelium 
with underlying submucosa and smooth muscle cell layers organized in a loose arrangement 
together with connective tissue (Fig. 3.27B-4 right). 
 
3.3.8. Pax8 mRNA Expression in the Reproductive System 
To determine whether the reproductive disturbances observed in T4-treated Pax8-/- animals of 
both genders could be directly related to the inactivation of the Pax8 gene, ISH was used to 
identify Pax8 transcripts in the reproductive system of adult wildtype mice. In male mice, 
strong mRNA expression was observed in the epithelium of the epididymis and with weaker 
intensity in the efferent ducts whereas no signal could be found in the testis (Fig 3.28).  
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Fig. 3.28: In situ hybridization analysis showing Pax8 mRNA expression in the male reproductive system of 
adult wildtype mice (A). Higher magnifications of the epididymis (EP) and the efferent duct (ED) are shown in 
(B) and (D) with the corresponding cresyl violet staining (C and E). No expression was observed in the testis (T). 
Scale bar left 1mm; right 500µm. 
 
In the female reproductive system of premature 3-week-old as well as sexually mature 
wildtype mice, Pax8 transcripts were detected in the entire uterine epithelium as well as in the 
luminal epithelium of the oviduct, the cervix, and the vagina, but not in the ovaries (Fig. 
3.29).  
 
Fig. 3.29: mRNA expression of Pax8 in the female reproductive tract of wildtype mice as assessed by radioactive 
ISH (darkfield pictures: overview in A, higher magnifications in B and D) with corresponding cresyl violet 
staining (brightfield pictures: C and E). The epithelium of the oviducts (arrow) and the uterus showed Pax8 
mRNA transcripts, but the ovaries did not exhibit Pax8 mRNA expression (asterisk). Scale bar left 3mm, right 
1mm.  
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To further investigate whether Pax8 gene expression might also play a role in the human 
reproductive system, Pax8 mRNA expression was analyzed in human endometrial tissue 
samples (Fig. 3.30). Corresponding to the situation in the mouse, strong signals of Pax8 
transcripts were observed in the luminal and glandular epithelium of the human endometrium 
in the secretory (Fig. 3.30A) or the proliferative phase (Fig. 3.30C) of the cycle. 
 
 
Fig. 3.30: In human endometrial samples of the secretory (A) and proliferative (C) phase, Pax8 mRNA 
expression was detected by radioactive ISH in the glandular (GE) and luminar epithelium (LE) of the 
endometrium. Corresponding cresyl violet stainings of neighbouring sections are shown under brightfield 
illumination in (B) and (D). Scale bar 150µm. 
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4. Discussion 
4.1. Pax8 Deficient Mice Cannot be Rescued by the Inactivation of TRα1 
Pax8-/-TRα1-/- mice were generated by breeding Pax8+/-TRα1-/- mice. Since Pax8+/- mice are 
not different from wildtype controls (Friedrichsen et al. 2004), it was not surprising that 
Pax8+/-TRα1-/- animals developed like TRα1-/- mice and exhibited the same characteristics. 
Although it was reported that TH levels are reduced only in TRα1-/- mutant males (Wikström 
et al. 1998), slightly altered serum T4 and T3 levels were observed in both genders. This is in 
good agreement with other reports (Amma et al. 2001, Dellovade et al. 2000). Phenotypically 
Pax8-/-TRα1-/- double knockout mice closely resembled Pax8-/- animals implying that the lack 
of TH mainly determines the phenotype, which is characterized by severe growth retardation 
and death around weaning. These defects could be prevented by treatment with TH in both 
athyroid animal models alike. 
In Pax8-/-TRα1-/- and Pax8-/- mice, the absence of TH similarly affected the relative tissue 
weight of most organs while the absence of TRα1 caused only minor defects. In brain, not 
only the absence of TH but also the absence of TRα1 led to an increased relative tissue 
weight. This is not too surprising since in contrast to TRβ, TRα1 is known to be already 
expressed during early embryonic stages where it might exert a suppressive function on tissue 
development (Schreiber et al. 2001). Since Pax8-/- animals lack the stimulatory effects of TH 
as a differentiation factor (Porterfield and Hendrich 1993), it could be speculated that the 
increased brain mass may be the result of a prolonged proliferation phase during 
development.  
With regard to the pituitary, cellular composition and mRNA levels of the anterior pituitary 
hormones were not different in TRα1-/- and Pax8+/-TRα1-/- mice and comparable to control 
animals indicating that TRα1 is of minor importance in pituitary development and hormonal 
regulation. Correspondingly, pituitaries of Pax8-/-TRα1-/- mice closely resembled those of 
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Pax8-/- mice (Friedrichsen et al. 2004). Both mutants exhibited a dramatically distorted 
cellular composition namely severe hypertrophy and hyperplasia of thyrotrophs and an almost 
complete absence of lactotrophs. 
The lack of TH is also the decisive factor determining the mortality of the athyroid animals, 
since these mice could be rescued by TH treatment. This contrasts with the fact that the 
absence of all T3 binding receptors has no lethal consequences as shown in TRα1-/-TRβ-/- 
compound mutants (Göthe et al. 1999), which are viable and survive to adulthood. 
Astonishingly enough, Pax8-/- mice can be rescued by the inactivation of the entire TRα gene, 
which has been taken as an indication that the mortality of the athyroid animals is the 
consequence of a lethal TRα1 aporeceptor activity (Flamant et al. 2002). This is not supported 
by the fact that Pax8-/-TRα1-/- mice do not survive weaning. Since these mice lack TRα1, this 
receptor isoform cannot exert any negative effects as an aporeceptor. It rather indicates that 
the TRα2 isoform, still expressed in the compound mutants, might be involved, although it is 
unable to bind T3 (Wikström et al. 1998). It could also be speculated that TR∆α2 might play a 
role in postweaning survival because TRα-/- mice in which TRα1 and TRα2 have been deleted 
and only the ∆α isoforms are expressed (Fraichard et al. 1997, Gauthier et al. 2001), show a 
more severe phenotype than TRα1-/- or TRαo/o mutants including early death after weaning. 
However, the physiological functions of the ∆α isoforms are still enigmatic, they lack DNA 
binding properties and have not yet been detected at the protein level. In contrast, TRα2 is 
indeed expressed as protein in vivo and is able to bind to DNA as a heterodimer with RXR 
(O’Shea 2002). Moreover, TRα2 is also known to act as a dominant negative inhibitor of TRE 
driven transcription and is considered as a weak antagonist although not as potent as 
unliganded TRs (Tagami et al. 1998, Macchia et al. 2001). 
Together with the fact that Pax8-/-TRα1-/- mice can be rescued by the administration of TH, 
this finding suggests a hypothetical model implying a complex formation of TRα2 with 
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another TR isoform capable of binding T3. Such a complex involving an unliganded isoform 
like TRβ in the Pax8-/-TRα1-/- mouse or TRα1 in the Pax8-/-TRβ-/- animals might be 
responsible for the mortality of these mutants around weaning time. This model would also 
explain why TRα1-/-TRβ-/- mice that still express TRα2 can survive to adulthood because 
these compound mutants are devoid of a T3 binding TR isoform (Göthe et al. 1999). The 
analysis of the mortality in Pax8-/-TRα2-/- double mutant mice, which is currently under 
investigation, might help to solve this puzzle. 
The Pax8-/-TRα1-/- mouse is also a valuable animal model to identify genes that are 
predominantly regulated by TRα1 as shown by the example of deiodinase type II gene 
expression. The mRNA of this gene is highly upregulated under the athyroid conditions of the 
Pax8-/- mouse, but this upregulation is at least partially abolished in Pax8-/-TRα1-/- animals, 
indicating that unliganded TRα1 is important for this process. With regard to the enzymatic 
activity the abrogated increase in Pax8-/-TRα1-/- animals is less pronounced than in Pax8-/- 
mice, because deiodinase type II activity is mainly negatively regulated posttranslationally by 
T4 and both mice lack this regulatory mechanism (Gereben et al. 2000). However, in light of 
embryonic development, when TRα1, but not TRβ, is expressed already at early stages and 
TH availability is still limited, it may be speculated, that the TRα1 aporeceptor activity 
induces deiodinase type II mRNA expression. This notion is supported by the fact that in 
some tissues the expression of deiodinase type II precedes the response to the differentiating 
effects of TH as shown in Xenopus laevis (Cai et al. 2004). With regard to the hypothalamus-
pituitary-thyroid axis the upregulation of D2 under athyroid conditions is even more 
important, since D2 is absolutely required for TH action in pituitary thyrotrophs as 
demonstrated by its localization in these cells.  
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4.2. Mediators of Thyroid Hormone Action in the Anterior Pituitary 
TH is important for proper pituitary function and maintenance. This becomes most evident in 
the congenital hypothyroid Pax8 null mouse which exhibits a completely deranged cellular 
composition of the anterior pituitary such as hypertrophy and hyperplasia of the thyrotrophs 
and the almost complete absence of lactotrophs cells (Friedrichsen et al. 2004). Whereas the 
former effect is easily explained by the missing negative feedback of TH, the cause for the 
latter is not easily explained, since TH dependent factors interfering with lactotroph activity 
and development have not been identified yet. 
In order to search for putative mediators of TH action in the pituitary, we compared the 
mRNA expression profile from wildtype and Pax8 deficient animals at 3 weeks of age by 
microarray analysis. Several genes were found to be differentially expressed, among them 
tyrosine hydroxylase, the rate-limiting enzyme of dopamine synthesis. Since dopamine is 
known to be the major regulator of prolactin synthesis and secretion (Ben-Jonathan et al. 
2001), the role of this gene in the pituitary with regard to the regulation by TH was analyzed 
in further detail. 
While the existence of tyrosine hydroxylase in the anterior pituitary was already postulated by 
some investigators (Schussler et al. 1992, Schussler et al. 1995), others failed to detect 
enzymes for dopamine synthesis in this tissue (Saavedra et al. 1975, Bäck et al. 1987). 
Regarding the low expression level and activity of tyrosine hydroxylase found in pituitaries of 
euthyroid wildtype mice, it is still uncertain whether this enzyme contributes to the dopamine 
level under physiological conditions. However, under hypothyroid or athyroid conditions as in 
Pax8 deficient mice, tyrosine hydroxylase located in pituitary thyrotrophs does contribute to 
an increased dopamine level in this tissue and thus to a stronger suppression of prolactin 
mRNA expression. This suppression could be abolished by the treatment with the dopamine 
antagonist haloperidol, confirming that dopamine is indeed the factor responsible for the 
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reduced prolactin transcript levels in these mice. The inhibiting influence of dopamine seems 
to be much more potent than the increased TRH stimulus on lactotrophic cells, since adult 
Pax8-/- and TRH-R1-/-Pax8-/- animals that were treated with TH until P40 and then rendered 
hypothyroid exhibit high levels of prolactin mRNA implying that in these mice tyrosine 
hydroxylase and subsequent dopamine production are not sufficient to reduce prolactin 
transcripts effectively. The cause for this surprising observation remains unknown and 
warrants further investigations.  
Although treatment with the dopamine antagonist haloperidol restored the prolactin transcript 
levels in the few lactotrophs present in Pax8 deficient mice, it did not normalize the number 
of lactotrophic cells. Surprisingly, treatment of wildtype mice with the dopamine agonist 
bromocryptine also did not interfere with lactotroph development, although bromocryptine is 
known to be a very potent inhibitor of lactotroph proliferation and is frequently used in the 
treatment of human prolactinomas (Ben-Jonathan et al. 2001, Spinas and Fischli 2001). From 
these observations it can be concluded that in mice early postnatal development of lactotrophs 
is not critically influenced by dopamine, but severely dependent on proper TH supply. The 
identification of the unknown factor, that strongly regulates lactotroph development in a TH 
dependent manner, remains to be elucidated. 
The hypothesis that hyperprolactinemia in adult hypothyroid humans (Roberts and Ladenson 
2003) and increased prolactin transcript levels in adult hypothyroid mice can be caused by an 
increased TRH stimulus, could be supported by the analysis of generated TRH-R1-/-Pax8-/- 
double mutant mice, that did not exhibit increased prolactin mRNA expression levels when 
rendered hypothyroid at 6 weeks of age. Although both cell types, lactotrophs and 
thyrotrophs, cannot respond to increased hypothalamic TRH in these mice missing TRH-R1, 
pituitary thyrotrophs of TRH-R1-/-Pax8-/- animals still exhibited hyperplasia and hypertrophy. 
The result indicates that, in contrast to the lactotrophs, the increased TRH signalling cannot be 
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responsible for the overstimulation of the thyrotrophs under athyroid conditions. This 
contrasts with observations made in the TRH-/-TRβ-/- double mutant mouse (Nikrodhanond et 
al. 2006), that were taken as an indication that TRH is absolutely required for TSH synthesis. 
Whereas the loss of TRβ is at least partially compensated by TRα1 in the mouse, the negative 
feedback loop through TH is entirely abolished in Pax8-/-TRH-R1-/- double mutants. Thus, 
these mice are a better animal model to analyze thyrotroph activity than TRH-/-TRβ-/- 
compound mutants.  
Annexin A5 was another factor differentially expressed in pituitaries of wildtype and Pax8 
null mice. In contrast to the other annexins identified in the microarray analysis, A5 is already 
highly expressed in wildtype mice and detectable at the protein level, pointing to a functional 
role in the anterior pituitary not only under pathological conditions. To further test this 
hypothesis, annexin A5 deficient mice were analyzed with regard to the mRNA expression of 
adenohypophyseal hormones. The TH sensitive genes β-TSH and GH were found to be 
unaffected by the lack of A5, indicating normal TH metabolism in these mice. Prolactin 
mRNA was also not altered, although it had been reported that in vitro exceedingly high 
concentrations of A5 inhibit the TRH stimulus on lactotrophs (Kawaminami et al. 1992, 
Kawaminami et al. 2004).  
Interestingly, mRNA levels of the gonadotropins were reduced in A5-/- animals, which is in 
good agreement with the report suggesting that A5 is involved in the GnRH mediated 
stimulation of gonadotrophs (Kawaminami et al. 2002). The finding that the loss of A5 leads 
to decreased gonadotropin production corresponds well with the observation that A5 
augments gonadotropin secretion in vitro (Kawaminami et al. 2002). However, the reduced 
gonadotropin mRNA expression does not seem to impair the reproductive capacity of these 
mice (Brachvogel et al. 2003). 
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In summary, two genes have been identified so far, that are involved in mediating TH action 
in the anterior pituitary. Tyrosine hydroxylase, upregulated under athyroid conditions, seems 
to suppress prolactin synthesis by locally increasing dopamine production, whereas annexin 
A5, downregulated in congenital hypothyroid Pax8-/- mice, might possibly modulate 
gonadotropin release. Some other differentially regulated genes could also be promising 
candidates for further investigations especially with regard to the lactotroph development. 
Calcitonin-gene-related peptide (see Table 3.2, p.29) has already been associated with 
inhibition of prolactin synthesis and lactotroph proliferation in vitro (Ren et al. 2001). The 
best approach to investigate an involvement in pituitary development and maintenance in vivo 
of course would be to analyze mice with a targeted deletion of this gene (Lu et al. 1999).  
 
4.3. Infertility of T4-Treated Pax8 Deficient Mice 
Since TH replacement therapy, if instituted immediately after birth, usually prevents all 
symptoms resulting from CH (Cassio et al. 2003, Roberts and Ladenson 2004, Larsen et al. 
2003), it was surprising that Pax8-/- mice of both genders were unable to reproduce despite 
proper T4 substitution. As a first approach to identify the reasons for this infertility, the 
hormonal situation in these mice was analyzed. The normal mRNA expression of all pituitary 
hormones especially β-TSH and GH confirmed a proper supply with TH, since these genes 
are highly sensitive to changes in TH metabolism (Yen et al. 2001, Friedrichsen et al. 2004).  
Normal serum testosterone as well as normal estrogen and progesterone levels also indicated 
an unimpaired hormonal situation in male and female mice respectively. No endocrine 
differences were found in the T4-treated Pax8-/- animals, confirming that the hormonal status 
is completely restored by TH replacement therapy. Taken together, these observations 
indicate that the infertility in Pax8 deficient animals is not related to any hormonal imbalance, 
but rather might be a direct consequence due to the lack of the Pax8 gene.  
Discussion 
 58
4.3.1. Infertility of Male T4-Treated Pax8 Deficient Mice 
For comparison with Pax8 null mice lacking TH as signalling molecule, TRα1-/-TRβ-/- double 
mutant male mice (Göthe et al. 1999) were analyzed in order to identify possible defects due 
to impaired TH signalling. The presence of motile spermatozoa in these mice supports the 
hypothesis that the absence of sperm from the epididymal lumen in T4-treated Pax8-/- mice is 
not related to disturbances in TH metabolism. The impaired velocity of spermatozoa observed 
in TRα1-/-TRβ-/- animals corresponds well with previous reports showing decreased sperm 
motility in hypothyroid rats (Kumar et al. 1994, Chandrasekhar et al. 1985).  
The situation in Pax8 deficient mice which completely lack sperm in the epididymal lumen is 
obviously more severe than in TRα1-/-TRβ-/- animals. The efferent ducts of Pax8 null mice 
exhibit a thickened connective tissue which narrows the lumen and hampers the passages of 
secretions. Together with the histological observations of a distension of the proximal efferent 
ducts, this indicates that the physical capacity of the post-testicular excurrent ducts might not 
be sufficient to transmit all the testicular fluid to the epididymis. The increasing testicular 
fluid secretion occurring at puberty leads to a gradual build-up of pressure within the testis 
which damages the seminiferous epithelium and leads to an arrest in spermatogenesis 
comparable to the situation in mice with ligations of the efferent duct (Ross et al. 1974) or in 
mice deficient in the estrogen receptor α which are unable to absorb water in these ducts 
(Korach et al. 1994).  
In mammals, the male reproductive system except for the testis is derived from the 
mesonephric or Wolffian duct, which degenerates in the female embryo due to the absence of 
testosterone (MacLaughlin et al. 2001). In mice, around embryonic day (E) 13.5, the 
derivatives of this mesonephric duct start forming the efferent ductules that connect the rete 
testis with the upper part of the epididymis which itself is derived from the most rostral 
mesonephric tubules (Brune et al. 1999). Pax8 expression is already detectable at E9.5 in the 
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developing Wolffian duct and the kidney and later at E15.5 also in the epididymis (Mansouri 
et al. 1994, Bouchard et al. 2004).  
In contrast to Pax2-deficient mice, which entirely lack kidneys and genital tracts (Torres et al. 
1995), the anterior-posterior patterning is well established in male Pax8-/- mice which display 
an unaffected differentiation of the Wolffian duct into efferent duct, epididymis and vas 
deferens. Thus, the loss of Pax8 can be compensated for by other factors such as Pax2 in the 
early developmental events of the male urogenital system, but Pax8 seems to play a pivotal 
role for the proper morphogenesis of the efferent duct and the epididymis in later 
developmental stages.  
Since in adult mice Pax8 is still expressed in the epithelium of epididymis and efferent ducts, 
it might have an additional function not only for the development but also for the maintenance 
of these tissues, making it a putative target for male contraception studies. 
As an additional conclusion of this study, one might suggest to analyze congenital 
hypothyroid male patients with mutations in the Pax8 gene, since like Pax8-/- mice they might 
be similarly affected. These patients would be good candidates for Intracytoplasmatic Sperm 
Injection (ICSI) therapy which can be performed with elongated testicular spermatids. 
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4.3.2. Infertility of Female T4-Treated Pax8 Deficient Mice 
The female reproductive tract in mammals is derived from the Müllerian duct, which 
degenerates at E13.5 in the male embryo due to the effects of the Anti-Müllerian-Hormone 
(MacLaughin et al. 2001). In humans, this reproductive tract development is not affected by 
fetal hypothyroidism (Krassas et al. 2000), whereas in rats, it has been associated with smaller 
ovaries and follicles, an underdeveloped uterus and vagina as well as delayed vaginal opening 
(Choksi et al. 2003). Since Pax8-/- animals are born by euthyroid Pax8+/- mothers, fetal thyroid 
hormone supply is not seriously affected in these mice, which is in good agreement with the 
fact that the ovaries of the T4-treated Pax8 deficient animals are normal; however, the uterus 
is absent and vaginal opening does not occur at all, indicating that this severe developmental 
impairment like in male mice relates also to the lack of the Pax8 gene during development. 
In addition to the expression in various tissues such as the thyroid gland, inner ear, pro-, 
meso- and metanephros, the cloaca and the mid-hindbrain boundary region during 
embryogenesis (Bouchard et al. 2002, Plachov et al. 1990), Pax8 expression has also been 
found in the epithelium of the Müllerian duct (Vainio et al. 1999), which differentiates into 
the oviducts, uterus, cervix and the upper portion of the vagina along the anterioposterior axis. 
In rodents, the epithelial invaginations of the mesonephros which form the Müllerian duct 
occur around E11.5 and extend posteriorly reaching the cloaca at ~E13.5 (Kobayashi and 
Behringer 2003) then forming a duplex uterus and dual cervix (Spencer et al. 2005). The 
different segments of the female reproductive tract exhibit distinct morphologies and 
cytoarchitecture (Cunha 1975), and the postnatal establishment of uterine histoarchitecture 
forming the different elements of the uterine wall, that are endometrium, myometrium and 
perimetrium, is not completed until two weeks after birth (Cunha 1976, Vernerova et al. 1993, 
Kurita et al. 2001). Pax8 seems to play an important role in this postnatal differentiation of the 
Müllerian duct forming an adequate histoarchitecture of the uterus since Pax8 null mutant 
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mice exhibit only remnants of myometrium and completely lack endometrial structures. 
Interestingly, the appropriate development of the oviduct, cervix and vagina is not affected.  
Patterning events required for differentiation from the Müllerian derivatives occur in both the 
anterioposterior and radial axes (Spencer et al. 2005). Obviously, anterioposterior patterning 
establishing histologically distinct segmental boundaries between the oviducts and the uterus 
as well as between the uterus and cervix is not disturbed in T4-treated Pax8-/- mice, but these 
animals display defects in radial patterning establishing the tissue-specific uterine 
morphology. 
In addition to the lack of a functional uterus, adult T4-substituted Pax8 deficient mice also 
lack a vaginal opening although the vaginal development is normal. In wildtype mice, the 
opening of the vagina occurs at about 6 to 7 weeks of age, around the onset of sexual maturity 
(Green 1975). It is known that developmental defects in the caudal sections of the urogenital 
tract can result in an imperforate vagina which may lead to the accumulation of secretion 
products and subsequently in a marked distention of the vagina (Jubb et al. 1985). The 
persistence of an imperforate vagina in the mouse is believed to be inherited in a recessive 
manner (Gruneberg 1952), and the role of Pax8 in this developmental step is not known yet. 
Alternatively, one could also speculate that certain factors secreted by the ovaries or the 
uterus itself are necessary for vaginal opening and the delivery of these factors is impaired by 
the lack of the uterus.  
Obviously, the lack of Pax8 expression can be compensated for by other factors during fetal 
development of the oviduct, cervix and vagina, but not in the postnatal development of the 
uterine histoarchitecture. Although Pax8 has been shown to be expressed in the entire 
Müllerian duct (Mansouri et al. 1998, Kobayashi and Behringer 2003), the absence of the 
Pax8 gene leads to a lack of the mucosal layer, the endometrium, only in the uterus, but not in 
the other tissues developing from this embryonal structure. 
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Redundantly acting transcription factors could be responsible for the normal development of 
these other parts of the reproductive tract. Coexpression of Pax2 with Pax8 has already been 
demonstrated in the developing Müllerian duct as well as in the kidney (Mansouri et al. 1998; 
Kobayashi and Behringer 2003), and an overlapping gene function has been shown for Pax2 
and Pax8 during development of the mouse urogenital system (Bouchard et al. 2002, Hans et 
al. 2004). This compensation obviously does not apply for uterine development. While 
embryonic development of the Müllerian duct does not seem to be disturbed in Pax8 deficient 
mice, the degeneration of the Müllerian duct during embryogenesis in Pax2 null mutants 
cannot be compensated for by Pax8 leading to a complete lack of the uterus and oviducts in 
these mice (Torres et al. 1995). However, one may speculate that Pax2 can at least partly 
compensate for Pax8 during the development of the oviduct, cervix and vagina, but the exact 
molecular mechanisms of Pax8 in this process remain unknown. 
Prenatal organogenesis as well as postnatal morphogenesis of the reproductive system is 
obviously a complex, multifactorial process. Pax8 seems to be an important player in the 
genetic pathway leading to female reproductive tract development. Similar to mouse 
embryonic development, Pax8 is also expressed in various structures of the human embryo 
such as the thyroid anlage, the otic vesicle, the mid-hindbrain boundary and in the 
metanephric blastema and derivatives (Trueba et al. 2005). Mutations of Pax8 found in human 
patients have been associated with the pathogenesis of thyroid dysgenesis and hypoplasia 
(Macchia et al. 1998, Meeus et al. 2004, Villain et al. 2001). Nowadays these disorders do not 
lead to symptoms of cretinism since congenital hypothyroid patients are identified in early 
postnatal screenings and adequately treated with T4. However, female patients with Pax8 
mutations have not yet been analyzed with regard to fertility and the development of their 
uterus. The observation that Pax8 is expressed not only in the uterine epithelium of mice but 
also in human tissue samples seems to indicate that the development of the endometrium 
might also be impaired in these women, which warrants further investigation. 
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5. Summary 
Thyroid hormones are essential for normal vertebrate development and for the metabolic 
homeostasis of almost all tissues. The physiological importance of thyroid hormone becomes 
most evident under the conditions of congenital hypothyroidism (CH), a common disorder 
occurring in 1 among 3600 newborns. If not treated immediately after birth by thyroid 
hormone substitution, CH leads to a syndrome called cretinism that is characterized by 
metabolic disturbances, severe neurological defects, mental deficiencies and growth 
retardation. The Pax8-/- mouse is an ideal animal model for congenital hypothyroidism, since 
it is born without thyroid follicular structures and thus this mouse is completely athyroid in 
postnatal life. Consequently, these mice exhibit ataxia, deafness, growth retardation, a 
completely distorted cellular composition of the anterior pituitary and they die around 
weaning. The analysis of the underlying molecular mechanisms of some of these symptoms 
was the aim of this thesis.  
In order to analyze the cause for the mortality, Pax8-/-TRα1-/- mice were generated by 
intercrossing Pax8+/- and TRα1-/- mice. This was of special interest, since Flamant et al. 
recently reported that Pax8-/- mice can be rescued by the inactivation of the entire thyroid 
hormone receptor α gene (Pax8-/-TRα0/0) (Flamant et al. 2002). The observation was taken as 
an indication for a lethal aporeceptor activity of TRα1, the only isoform of the TRα gene that 
is considered as a functional TR, because it is able to bind T3 as well as DNA. However, as 
shown in this study, Pax8-/-TRα1-/- mice exhibit the same phenotype as Pax8-/- mice, including 
growth retardation, deranged pituitary appearance and death around weaning. Therefore it 
could be excluded that TRα1 is responsible for the death around weaning, suggesting that the 
mortality is most likely associated with the TRα2 isoform. Due to the fact, that Pax8-/- as well 
as  Pax8-/-TRα1-/- mice could be rescued by thyroxine treatment, it was assumed, that TRα2 
has to interact with a functional unliganded TR isoform to cause death in these animals. 
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To identify factors, which contribute to the distorted cellular make-up of the pituitary in 
athyroid mice, a microarray based analysis was performed. Several genes were found to be 
differentially expressed in pituitaries of Pax8-/- mice compared to wildtype animals, among 
them tyrosine hydroxylase, which is transcriptionally and functionally upregulated in Pax8-/- 
mice, leading to an increase in the local production of dopamine. Consequently, prolactin 
mRNA expression is inhibited in these animals. However, as demonstrated by the use of 
dopamine antagonists and agonists, postnatal lactotroph development is not impaired. Since in 
humans hypothyroidism is often associated with hyperprolactinemia, adult thyroxine treated 
Pax8 deficient mice were made hypothyroid by stopping thyroxine treatment. By this 
manipulation it could be shown that in contrast to the young P21 animals, hypothyroidism 
causes an increase in prolactin mRNA expression. In contrast, after the induction of 
hypothyroidism, adult TRH-R1-/-Pax8-/- double mutant mice did not show an upregulation of 
prolactin transcript levels, suggesting that the increase in prolactin transcript levels under 
hypothyroid conditions is caused by an increased TRH stimulus. It remains unknown, why the 
increase in tyrosine hydroxylase, which was also found in pituitaries of adult hypothyroid 
mice, is not sufficient to suppress prolactin mRNA expression, and why the increased TRH 
stimulus in young Pax8-/- mice does not cause increased prolactin mRNA expression in these 
animals.  
Besides tyrosine hydroxylase, annexin A5 was also identified as a pituitary gene which is 
positively regulated by thyroid hormones. In good agreement with reported in vitro data, the 
loss of annexin A5 seems to impair gonadotropin synthesis also in vivo. This was 
demonstrated by the analysis of A5 deficient mice which revealed a decreased mRNA 
expression of β-FSH. The expression of the other pituitary hormones was found not to be 
affected by the lack of A5 and an involvement of A5 in the TRH mediated regulation of 
prolactin, as reported by other investigators, could not be confirmed. 
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Some other genes were also identified to be differentially expressed in Pax8 null mice, like 
calcitonin-gene-related peptide or STAT1 and STAT4. Whether these genes also contribute to 
the deranged appearance of the pituitary under athyroid conditions remains to be elucidated. 
Since usually all symptoms of congenital hypothyroidism can be reversed by thyroid hormone 
replacement therapy, it was very surprising that Pax8-/- mice of both genders were infertile 
despite proper TH treatment. The analysis revealed that Pax8 deficient females lack the entire 
uterus and do not have a vaginal opening and Pax8 deficient male mutants do not have any 
sperm in the epididymis. With age, these mice develop considerable atrophy of their testis due 
to a narrowed passage in the efferent ducts. Since the hormonal situation was not impaired in 
thyroxine treated Pax8 null mice, these defects seem to be directly related to the inactivation 
of the Pax8 gene. This notion is supported by the identification of Pax8 mRNA expression in 
the epithelium of the uterus and the oviducts as well as the epithelium of the efferent ducts 
and the epididymis of wildtype mice. Taken together, these observations indicate an important 
role for Pax8 during the development of the uterus and the efferent ducts. Since Pax8 mRNA 
expression was also demonstrated in human endometrial tissue samples, it remains to be 
elucidated whether human patients with mutations in the Pax8 gene are similarly affected. 
Taken together, we were able to elucidate the underlying molecular mechanisms of some 
defects observed under the conditions of congenital hypothyroidism using the Pax8-/- animal 
model namely the mortality of these animals as well as the reduced prolactin and 
gonadotropin mRNA expression in the anterior pituitary of these mice. By analyzing the 
infertility of T4-treated Pax8 deficient mice, we identified Pax8 as a novel key player in the 
development of the male and female reproductive system. 
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7. Non-Standard Abbreviations 
ACTH  adrenocorticotrophic hormone 
bw  bodyweight 
CH  congenital hypothyroidism 
cpm  counts per minute 
D1  deiodinase type I 
D2  deiodinase type II 
D3  deiodinase type III 
EDTA  ethylene diamine tetra acetic acid 
FSH  follicle stimulating hormone 
GH  growth hormone 
LH  luteinizing hormone 
min  minute 
nt  nucleotide 
Pax  paired box gene 
POMC  proopiomelanocortin 
PRL  prolactin 
RT  room temperature 
SDS  sodium duodecyl sulphate 
T3  triiodthyronine 
T4  tetraiodthyronine, thyroxine 
TH  thyroid hormone 
TR  thyroid hormone receptor 
TRH  thyrotropin releasing hormone 
TRH-R1 thyrotropin releasing hormone receptor 1 
TSH  thyroid stimulating hormone 
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